[P02BB01, trichlorfon, Metrifonate may increase the neuromuscular blocking activities of Procaine.]
[S02DA03, antipyrine, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Antipyrine.]
[B01AD01, streptokinase, Procaine may increase the orthostatic hypotensive activities of Streptokinase.]
[J01GA01, streptomycin, The risk or severity of methemoglobinemia can be increased when Streptomycin is combined with Procaine.]
[L01AD04, streptozocin, The risk or severity of methemoglobinemia can be increased when Streptozocin is combined with Procaine.]
[M03AB01, succinylcholine, The metabolism of Succinylcholine can be decreased when combined with Procaine.]
[J01CA16, sulbenicillin, The risk or severity of methemoglobinemia can be increased when Sulbenicillin is combined with Procaine.]
[S01AB04, sulfacetamide, The risk or severity of methemoglobinemia can be increased when Sulfacetamide is combined with Procaine.]
[J01EC02, sulfadiazine, The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Procaine.]
[J01ED07, sulfamerazine, The risk or severity of methemoglobinemia can be increased when Sulfamerazine is combined with Procaine.]
[J01EC01, sulfamethoxazole, The risk or severity of methemoglobinemia can be increased when Sulfamethoxazole is combined with Procaine.]
[J01ED05, sulfamethoxypyridazine, The risk or severity of methemoglobinemia can be increased when Sulfamethoxypyridazine is combined with Procaine.]
[J01EB06, sulfanilamide, The risk or severity of methemoglobinemia can be increased when Sulfanilamide is combined with Procaine.]
[J01EB04, sulfapyridine, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The risk or severity of methemoglobinemia can be increased when Sulfisoxazole is combined with Procaine.]
[N05AL01, sulpiride, Sulpiride may increase the neuromuscular blocking activities of Procaine.]
[N03AX03, sulthiame, The risk or severity of methemoglobinemia can be increased when Sulthiame is combined with Procaine.]
[A10BB04, glibornuride, Procaine may increase the hypoglycemic activities of Glibornuride.]
[A10BC01, glymidine, Procaine may increase the hypoglycemic activities of Glymidine.]
[L01BB02, mercaptopurine, The risk or severity of methemoglobinemia can be increased when Mercaptopurine is combined with Procaine.]
[N06DA01, tacrine, Tacrine may increase the neuromuscular blocking activities of Procaine.]
[J01CA15, talampicillin, The risk or severity of methemoglobinemia can be increased when Talampicillin is combined with Procaine.]
[L02BA01, tamoxifen, The risk or severity of methemoglobinemia can be increased when Tamoxifen is combined with Procaine.]
[N05CD07, temazepam, The risk or severity of adverse effects can be increased when Temazepam is combined with Procaine.]
[L01CB02, teniposide, The risk or severity of methemoglobinemia can be increased when Teniposide is combined with Procaine.]
[R03CC03, terbutaline, Terbutaline may increase the neuromuscular blocking activities of Procaine.]
[B01AE07, dabigatran etexilate, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Dabigatran etexilate.]
[N07XX06, tetrabenazine, The risk or severity of adverse effects can be increased when Procaine is combined with Tetrabenazine.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Tetracaine.]
[S03AA02, tetracycline, The risk or severity of methemoglobinemia can be increased when Tetracycline is combined with Procaine.]
[J01DI02, ceftaroline fosamil, The risk or severity of methemoglobinemia can be increased when Ceftaroline fosamil is combined with Procaine.]
[N05AE05, lurasidone, The risk or severity of adverse effects can be increased when Procaine is combined with Lurasidone.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Procaine.]
[N04BC07, apomorphine, Procaine may increase the orthostatic hypotensive activities of Apomorphine.]
[L04AX02, thalidomide, Procaine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[L01XX41, eribulin, The risk or severity of methemoglobinemia can be increased when Eribulin is combined with Procaine.]
[J01BA02, thiamphenicol, The risk or severity of methemoglobinemia can be increased when Thiamphenicol is combined with Procaine.]
[R06AD03, thiethylperazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Thiethylperazine.]
[L01AC01, thiotepa, The risk or severity of methemoglobinemia can be increased when Thiotepa is combined with Procaine.]
[L01BB03, thioguanine, The risk or severity of methemoglobinemia can be increased when Tioguanine is combined with Procaine.]
[N05CA19, thiopental, The risk or severity of methemoglobinemia can be increased when Thiopental is combined with Procaine.]
[N05AB08, thioproperazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Thioproperazine.]
[N05AC02, thioridazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Thioridazine.]
[N05AF04, thiothixene, The risk or severity of adverse effects can be increased when Procaine is combined with Thiothixene.]
[B02AB01, aprotinin, Aprotinin may increase the neuromuscular blocking activities of Procaine.]
[G04BE06, moxisylyte, Procaine may increase the neuromuscular blocking activities of Moxisylyte.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Procaine is combined with Tiapride.]
[J01CA13, ticarcillin, The risk or severity of methemoglobinemia can be increased when Ticarcillin is combined with Procaine.]
[B01AC05, ticlopidine, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Ticlopidine.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Tilidine is combined with Procaine.]
[S01ED01, timolol, Procaine may increase the bradycardic activities of Timolol.]
[P01AB02, tinidazole, The risk or severity of methemoglobinemia can be increased when Tinidazole is combined with Procaine.]
[S01AA12, tobramycin, The risk or severity of methemoglobinemia can be increased when Tobramycin is combined with Procaine.]
[A10BB05, tolazamide, Procaine may increase the hypoglycemic activities of Tolazamide.]
[M02AX02, tolazoline, Procaine may increase the hypotensive activities of Tolazoline.]
[V04CA01, tolbutamide, Procaine may increase the hypoglycemic activities of Tolbutamide.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Procaine is combined with Tolperisone.]
[N02AX02, tramadol, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Tramadol.]
[N06AF04, tranylcypromine, The risk or severity of adverse effects can be increased when Procaine is combined with Tranylcypromine.]
[C01DX11, trapidil, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Trapidil.]
[N06AX05, trazodone, Procaine may increase the serotonergic activities of Trazodone.]
[L01XF01, tretinoin, The risk or severity of methemoglobinemia can be increased when Tretinoin is combined with Procaine.]
[S01BA05, triamcinolone, The therapeutic efficacy of Procaine can be decreased when used in combination with Triamcinolone.]
[C03DB02, triamterene, Procaine may increase the orthostatic hypotensive activities of Triamterene.]
[N05CD05, triazolam, The risk or severity of adverse effects can be increased when Procaine is combined with Triazolam.]
[C03AA06, trichlormethiazide, Procaine may increase the hypotensive activities of Trichlormethiazide.]
[A03AB12, mepenzolate, Procaine may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[S01EB04, demecarium, Demecarium may increase the neuromuscular blocking activities of Procaine.]
[N05AB06, trifluoperazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Trifluoperazine.]
[S01AD02, trifluridine, The risk or severity of methemoglobinemia can be increased when Trifluridine is combined with Procaine.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Procaine is combined with Trifluperidol.]
[N05AA05, triflupromazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Triflupromazine.]
[D07AC02, fluclorolone, The therapeutic efficacy of Procaine can be decreased when used in combination with Fluclorolone.]
[N04AA01, trihexyphenidyl, Procaine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[R03BA07, mometasone, The therapeutic efficacy of Procaine can be decreased when used in combination with Mometasone.]
[A03AA05, trimebutine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.]
[R06AD01, trimeprazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Alimemazine.]
[N03AC02, trimethadione, The risk or severity of methemoglobinemia can be increased when Trimethadione is combined with Procaine.]
[C02BA01, trimethaphan, Procaine may increase the neuromuscular blocking activities of Trimethaphan.]
[N06AA06, trimipramine, Procaine may increase the serotonergic activities of Trimipramine.]
[R06AX07, triprolidine, The risk or severity of adverse effects can be increased when Triprolidine is combined with Procaine.]
[A03BB01, butylscopolamine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[J01FA08, troleandomycin, The risk or severity of methemoglobinemia can be increased when Troleandomycin is combined with Procaine.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be decreased when combined with Procaine.]
[S01FA06, tropicamide, The risk or severity of adverse effects can be increased when Procaine is combined with Tropicamide.]
[N06AX02, tryptophan, The risk or severity of serotonin syndrome and hypomania can be increased when Tryptophan is combined with Procaine.]
[C09CA09, azilsartan medoxomil, Procaine may increase the hypotensive activities of Azilsartan medoxomil.]
[M03AA02, tubocurarine, Procaine may increase the neuromuscular blocking activities of Tubocurarine.]
[L01FX04, ipilimumab, The risk or severity of methemoglobinemia can be increased when Ipilimumab is combined with Procaine.]
[S01AA05, tyrothricin, The risk or severity of methemoglobinemia can be increased when Tyrothricin is combined with Procaine.]
[L01EX04, vandetanib, The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Procaine.]
[L01AD08, uracil mustard, The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Procaine.]
[L02BX03, abiraterone, The risk or severity of methemoglobinemia can be increased when Abiraterone is combined with Procaine.]
[A10BH05, linagliptin, Procaine may increase the hypoglycemic activities of Linagliptin.]
[B01AD04, urokinase, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Urokinase.]
[A07AA12, fidaxomicin, The risk or severity of methemoglobinemia can be increased when Fidaxomicin is combined with Procaine.]
[S01AA28, vancomycin, The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Procaine.]
[N03AX21, ezogabine, The risk or severity of methemoglobinemia can be increased when Ezogabine is combined with Procaine.]
[B01AF01, rivaroxaban, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Rivaroxaban.]
[R03AC18, indacaterol, The risk or severity of adverse effects can be increased when Procaine is combined with Indacaterol.]
[B01AC24, ticagrelor, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Ticagrelor.]
[C08DA01, verapamil, Procaine may increase the orthostatic hypotensive activities of Verapamil.]
[N06AX09, viloxazine, The risk or severity of hypertension can be increased when Viloxazine is combined with Procaine.]
[L01CA01, vinblastine, The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Procaine.]
[C04AX07, vincamine, The risk or severity of methemoglobinemia can be increased when Vincamine is combined with Procaine.]
[L01CA02, vincristine, The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Procaine.]
[L01CA03, vindesine, The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Procaine.]
[B01AA03, warfarin, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Warfarin.]
[S01AA13, fusidic acid, The risk or severity of methemoglobinemia can be increased when Fusidic acid is combined with Procaine.]
[N01AX15, xenon, The risk or severity of adverse effects can be increased when Xenon is combined with Procaine.]
[C03BA10, xipamide, Procaine may increase the hypotensive activities of Xipamide.]
[J01MB04, pipemidic acid, The risk or severity of methemoglobinemia can be increased when Pipemidic acid is combined with Procaine.]
[N05AF05, zuclopenthixol, The risk or severity of adverse effects can be increased when Procaine is combined with Zuclopenthixol.]
[N03AX14, levetiracetam, The risk or severity of methemoglobinemia can be increased when Levetiracetam is combined with Procaine.]
[L01EC01, vemurafenib, The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Procaine.]
[M05BA03, pamidronic acid, The risk or severity of methemoglobinemia can be increased when Pamidronic acid is combined with Procaine.]
[L01FX05, brentuximab vedotin, The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Procaine.]
[L01ED01, crizotinib, The risk or severity of methemoglobinemia can be increased when Crizotinib is combined with Procaine.]
[B01AE01, desirudin, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Lepirudin.]
[L01XD05, temoporfin, The risk or severity of methemoglobinemia can be increased when Temoporfin is combined with Procaine.]
[J01MA13, trovafloxacin, The risk or severity of methemoglobinemia can be increased when Trovafloxacin is combined with Procaine.]
[L01XX02, asparaginase, The risk or severity of methemoglobinemia can be increased when Asparaginase Escherichia coli is combined with Procaine.]
[N05AE04, ziprasidone, The risk or severity of adverse effects can be increased when Procaine is combined with Ziprasidone.]
[L04AA34, alemtuzumab, The risk or severity of methemoglobinemia can be increased when Alemtuzumab is combined with Procaine.]
[N02BA01, aspirin, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The risk or severity of methemoglobinemia can be increased when Ruxolitinib is combined with Procaine.]
[G04BD07, tolterodine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.]
[J01DH04, doripenem, The risk or severity of methemoglobinemia can be increased when Doripenem is combined with Procaine.]
[C07AB03, atenolol, Procaine may increase the bradycardic activities of Atenolol.]
[L03AB11, peginterferon alfa-2a, The risk or severity of methemoglobinemia can be increased when Peginterferon alfa-2a is combined with Procaine.]
[L01FA01, rituximab, The risk or severity of methemoglobinemia can be increased when Rituximab is combined with Procaine.]
[M03AC04, atracurium, The risk or severity of adverse effects can be increased when Procaine is combined with Atracurium.]
[S01FA01, atropine, The risk or severity of hypertension can be increased when Procaine is combined with Atropine.]
[L01XJ01, vismodegib, The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Procaine.]
[L01EK01, axitinib, The risk or severity of methemoglobinemia can be increased when Axitinib is combined with Procaine.]
[H02AB11, prednylidene, The therapeutic efficacy of Procaine can be decreased when used in combination with Prednylidene.]
[L01BC07, azacitidine, The risk or severity of methemoglobinemia can be increased when Azacitidine is combined with Procaine.]
[L01BC05, gemcitabine, The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Procaine.]
[J01CA09, azlocillin, The risk or severity of methemoglobinemia can be increased when Azlocillin is combined with Procaine.]
[J01DF01, aztreonam, The risk or severity of methemoglobinemia can be increased when Aztreonam is combined with Procaine.]
[R02AB04, bacitracin, The risk or severity of methemoglobinemia can be increased when Bacitracin is combined with Procaine.]
[M03BX01, baclofen, The risk or severity of hypotension can be increased when Baclofen is combined with Procaine.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Procaine.]
[L01FD02, pertuzumab, The risk or severity of methemoglobinemia can be increased when Pertuzumab is combined with Procaine.]
[A08AA11, lorcaserin, The risk or severity of adverse effects can be increased when Procaine is combined with Lorcaserin.]
[G04BD12, mirabegron, Procaine may increase the neuromuscular blocking activities of Mirabegron.]
[L01XG02, carfilzomib, The risk or severity of methemoglobinemia can be increased when Carfilzomib is combined with Procaine.]
[L02BB04, enzalutamide, The risk or severity of methemoglobinemia can be increased when Enzalutamide is combined with Procaine.]
[A06AX04, linaclotide, The therapeutic efficacy of Linaclotide can be decreased when used in combination with Procaine.]
[L01EA04, bosutinib, The risk or severity of methemoglobinemia can be increased when Bosutinib is combined with Procaine.]
[B01AX01, defibrotide, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Defibrotide.]
[H02AA01, aldosterone, The therapeutic efficacy of Procaine can be decreased when used in combination with Aldosterone.]
[L01EX05, regorafenib, The risk or severity of methemoglobinemia can be increased when Regorafenib is combined with Procaine.]
[L01XL02, talimogene laherparepvec, The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Procaine.]
[N05CA04, barbital, The risk or severity of methemoglobinemia can be increased when Barbital is combined with Procaine.]
[L01AA09, bendamustine, The risk or severity of methemoglobinemia can be increased when Bendamustine is combined with Procaine.]
[S01GA07, brimonidine, The metabolism of Brimonidine can be decreased when combined with Procaine.]
[N04BD02, rasagiline, The risk or severity of adverse effects can be increased when Procaine is combined with Rasagiline.]
[C08CA13, lercanidipine, Procaine may increase the hypotensive activities of Lercanidipine.]
[A03FA09, mosapride, The risk or severity of adverse effects can be increased when Procaine is combined with Mosapride.]
[N06DA02, donepezil, The therapeutic efficacy of Procaine can be decreased when used in combination with Donepezil.]
[N03AX22, perampanel, Perampanel may increase the central nervous system depressant (CNS depressant) activities of Procaine.]
[N02CC03, zolmitriptan, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Zolmitriptan.]
[R06AC06, thonzylamine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, Procaine may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Diethyl ether is combined with Procaine.]
[L01EX07, cabozantinib, The risk or severity of methemoglobinemia can be increased when Cabozantinib is combined with Procaine.]
[L01EA05, ponatinib, The risk or severity of methemoglobinemia can be increased when Ponatinib is combined with Procaine.]
[B01AF02, apixaban, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Apixaban.]
[J04AK05, bedaquiline, The risk or severity of methemoglobinemia can be increased when Bedaquiline is combined with Procaine.]
[A10BH04, alogliptin, Procaine may increase the hypoglycemic activities of Alogliptin.]
[C03AA01, bendroflumethiazide, Procaine may increase the hypotensive activities of Bendroflumethiazide.]
[L04AX06, pomalidomide, The risk or severity of methemoglobinemia can be increased when Pomalidomide is combined with Procaine.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Procaine is combined with Benperidol.]
[A10BK02, canagliflozin, Procaine may increase the orthostatic hypotensive activities of Canagliflozin.]
[J01MA15, gemifloxacin, The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Procaine.]
[S01AE07, moxifloxacin, The risk or severity of methemoglobinemia can be increased when Moxifloxacin is combined with Procaine.]
[A06AX06, tegaserod, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Tegaserod.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Procaine is combined with Insulin detemir.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Benzocaine.]
[A10BX05, pramlintide, Procaine may increase the hypoglycemic activities of Pramlintide.]
[M01AH01, celecoxib, The risk or severity of methemoglobinemia can be increased when Celecoxib is combined with Procaine.]
[N02CC02, naratriptan, The risk or severity of adverse effects can be increased when Procaine is combined with Naratriptan.]
[L04AA18, everolimus, The risk or severity of methemoglobinemia can be increased when Everolimus is combined with Procaine.]
[N04AC01, benztropine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.]
[L01EC02, dabrafenib, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Procaine.]
[L01EE01, trametinib, The risk or severity of methemoglobinemia can be increased when Trametinib is combined with Procaine.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Benzyl alcohol.]
[L01EB03, afatinib, The risk or severity of methemoglobinemia can be increased when Afatinib is combined with Procaine.]
[N06AX28, levomilnacipran, Procaine may increase the serotonergic activities of Levomilnacipran.]
[C08EA02, bepridil, Procaine may increase the hypotensive activities of Bepridil.]
[C02KX05, riociguat, Procaine may increase the hypotensive activities of Riociguat.]
[A10BJ03, lixisenatide, Procaine may increase the hypoglycemic activities of Lixisenatide.]
[C02KX04, macitentan, Procaine may increase the hypotensive activities of Macitentan.]
[L01EL01, ibrutinib, The risk or severity of methemoglobinemia can be increased when Ibrutinib is combined with Procaine.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Procaine.]
[N03AF04, eslicarbazepine, The risk or severity of methemoglobinemia can be increased when Eslicarbazepine is combined with Procaine.]
[S01EA03, apraclonidine, Procaine may increase the alpha-adrenergic activities of Apraclonidine.]
[N03AG04, vigabatrin, The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Procaine.]
[A10BK01, dapagliflozin, Procaine may increase the orthostatic hypotensive activities of Dapagliflozin.]
[C01CA27, droxidopa, Procaine may increase the hypertensive activities of Droxidopa.]
[C07AB04, acebutolol, Procaine may increase the bradycardic activities of Acebutolol.]
[N05CH03, tasimelteon, The risk or severity of adverse effects can be increased when Procaine is combined with Tasimelteon.]
[P01CX04, miltefosine, The risk or severity of methemoglobinemia can be increased when Miltefosine is combined with Procaine.]
[L02BG02, formestane, The risk or severity of methemoglobinemia can be increased when Formestane is combined with Procaine.]
[N07CA01, betahistine, The metabolism of Betahistine can be decreased when combined with Procaine.]
[A16AA06, betaine, Betaine may increase the neuromuscular blocking activities of Procaine.]
[S03BA03, betamethasone, The therapeutic efficacy of Procaine can be decreased when used in combination with Betamethasone.]
[S01ED02, betaxolol, Procaine may increase the bradycardic activities of Betaxolol.]
[B01AE03, argatroban, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Argatroban.]
[C02CC01, bethanidine, Procaine may increase the hypotensive activities of Bethanidine.]
[C10AB02, bezafibrate, Procaine may increase the hepatotoxic activities of Bezafibrate.]
[A10BJ04, albiglutide, Procaine may increase the hypoglycemic activities of Albiglutide.]
[L04AC11, siltuximab, The risk or severity of methemoglobinemia can be increased when Siltuximab is combined with Procaine.]
[L01ED02, ceritinib, The risk or severity of methemoglobinemia can be increased when Ceritinib is combined with Procaine.]
[L01FG02, ramucirumab, The risk or severity of methemoglobinemia can be increased when Ramucirumab is combined with Procaine.]
[B01AC26, vorapaxar, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Vorapaxar.]
[J01XA04, dalbavancin, The risk or severity of methemoglobinemia can be increased when Dalbavancin is combined with Procaine.]
[A03BA03, hyoscyamine, Procaine may increase the anticholinergic activities of Hyoscyamine.]
[B01AA07, acenocoumarol, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Acenocoumarol.]
[J01XX11, tedizolid, The risk or severity of methemoglobinemia can be increased when Tedizolid is combined with Procaine.]
[L01XH04, belinostat, The risk or severity of methemoglobinemia can be increased when Belinostat is combined with Procaine.]
[L01EM01, idelalisib, The risk or severity of methemoglobinemia can be increased when Idelalisib is combined with Procaine.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Procaine is combined with Alfaxalone.]
[A10BK03, empagliflozin, Procaine may increase the orthostatic hypotensive activities of Empagliflozin.]
[R03AC19, olodaterol, The risk or severity of adverse effects can be increased when Procaine is combined with Olodaterol.]
[D11AA01, glycopyrronium, Procaine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[N05CM19, suvorexant, Procaine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[L01FF02, pembrolizumab, The risk or severity of methemoglobinemia can be increased when Pembrolizumab is combined with Procaine.]
[J01XA05, oritavancin, The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Procaine.]
[S01AA15, dihydrostreptomycin, The risk or severity of methemoglobinemia can be increased when Dihydrostreptomycin is combined with Procaine.]
[N05AA04, acepromazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Acepromazine.]
[V04CX03, methacholine, Procaine may decrease effectiveness of Methacholine as a diagnostic agent.]
[A06AB04, phenolphthalein, The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Procaine.]
[A10BJ05, dulaglutide, Procaine may increase the hypoglycemic activities of Dulaglutide.]
[A06AH03, naloxegol, The risk or severity of adverse effects can be increased when Procaine is combined with Naloxegol.]
[L01BC08, decitabine, The risk or severity of methemoglobinemia can be increased when Decitabine is combined with Procaine.]
[N04AA02, biperiden, Procaine may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[L04AX05, pirfenidone, The risk or severity of methemoglobinemia can be increased when Pirfenidone is combined with Procaine.]
[L01EX09, nintedanib, The risk or severity of methemoglobinemia can be increased when Nintedanib is combined with Procaine.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Procaine.]
[S03AA06, gentamicin, The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Procaine.]
[L01FX07, blinatumomab, The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Procaine.]
[L01XK01, olaparib, The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Procaine.]
[L01FF01, nivolumab, The risk or severity of methemoglobinemia can be increased when Nivolumab is combined with Procaine.]
[B01AA01, dicumarol, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Dicoumarol.]
[B01AF03, edoxaban, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Edoxaban.]
[N06AX11, mirtazapine, Procaine may increase the serotonergic activities of Mirtazapine.]
[L01EF01, palbociclib, The risk or severity of methemoglobinemia can be increased when Palbociclib is combined with Procaine.]
[L01EX08, lenvatinib, The risk or severity of methemoglobinemia can be increased when Lenvatinib is combined with Procaine.]
[L01XH03, panobinostat, The risk or severity of methemoglobinemia can be increased when Panobinostat is combined with Procaine.]
[N02BE01, acetaminophen, The risk or severity of methemoglobinemia can be increased when Acetaminophen is combined with Procaine.]
[L01DC01, bleomycin, The risk or severity of methemoglobinemia can be increased when Bleomycin is combined with Procaine.]
[A03AA09, difemerine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[B01AA11, tioclomarol, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Tioclomarol.]
[A07DA06, eluxadoline, The risk or severity of constipation can be increased when Procaine is combined with Eluxadoline.]
[B01AC25, cangrelor, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Cangrelor.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be decreased when combined with Procaine.]
[L01XJ02, sonidegib, The risk or severity of methemoglobinemia can be increased when Sonidegib is combined with Procaine.]
[G02CX02, flibanserin, The metabolism of Flibanserin can be decreased when combined with Procaine.]
[A06AD03, magnesium peroxide, The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Procaine.]
[N05AX15, cariprazine, The metabolism of Cariprazine can be decreased when combined with Procaine.]
[A10BF01, acarbose, Procaine may increase the hypoglycemic activities of Acarbose.]
[S01EC01, acetazolamide, The risk or severity of methemoglobinemia can be increased when Acetazolamide is combined with Procaine.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Procaine is combined with Insulin degludec.]
[N05AB07, acetophenazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Acetophenazine.]
[S02AA10, acetic acid, The risk or severity of methemoglobinemia can be increased when Acetic acid is combined with Procaine.]
[L01CX01, trabectedin, The risk or severity of methemoglobinemia can be increased when Trabectedin is combined with Procaine.]
[L01EB04, osimertinib, The risk or severity of methemoglobinemia can be increased when Osimertinib is combined with Procaine.]
[L01FC01, daratumumab, The risk or severity of methemoglobinemia can be increased when Daratumumab is combined with Procaine.]
[L01EE02, cobimetinib, The risk or severity of methemoglobinemia can be increased when Cobimetinib is combined with Procaine.]
[L01XG03, ixazomib, The risk or severity of methemoglobinemia can be increased when Ixazomib is combined with Procaine.]
[L01FE03, necitumumab, The risk or severity of methemoglobinemia can be increased when Necitumumab is combined with Procaine.]
[L01FX08, elotuzumab, The risk or severity of methemoglobinemia can be increased when Elotuzumab is combined with Procaine.]
[L01ED03, alectinib, The risk or severity of methemoglobinemia can be increased when Alectinib is combined with Procaine.]
[B01AC27, selexipag, Procaine may increase the hypotensive activities of Selexipag.]
[A10BB31, acetohexamide, Procaine may increase the hypoglycemic activities of Acetohexamide.]
[L01XA04, satraplatin, The risk or severity of methemoglobinemia can be increased when Satraplatin is combined with Procaine.]
[N05CA05, aprobarbital, The risk or severity of adverse effects can be increased when Procaine is combined with Aprobarbital.]
[N03AX23, brivaracetam, The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Procaine.]
[L01XX52, venetoclax, The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Procaine.]
[N05BA08, bromazepam, The risk or severity of adverse effects can be increased when Procaine is combined with Bromazepam.]
[N04BC01, bromocriptine, Procaine may increase the hypertensive activities of Bromocriptine.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Procaine is combined with Alverine.]
[R06AB01, brompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Procaine.]
[N06AA19, amineptin, Procaine may increase the serotonergic activities of Amineptine.]
[C08CA01, amlodipine, Procaine may increase the hypotensive activities of Amlodipine.]
[L01FF05, atezolizumab, The risk or severity of methemoglobinemia can be increased when Atezolizumab is combined with Procaine.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Procaine is combined with Aniracetam.]
[C03CA02, bumetanide, Procaine may increase the orthostatic hypotensive activities of Bumetanide.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Procaine.]
[C07AA19, bupranolol, Procaine may increase the bradycardic activities of Bupranolol.]
[N07BC01, buprenorphine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[L02AE01, buserelin, The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Procaine.]
[N05BE01, buspirone, The risk or severity of hypertension can be increased when Procaine is combined with Buspirone.]
[L01AB01, busulfan, The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Procaine.]
[L01XX27, arsenic trioxide, The risk or severity of methemoglobinemia can be increased when Arsenic trioxide is combined with Procaine.]
[N06DA03, rivastigmine, Rivastigmine may increase the neuromuscular blocking activities of Procaine.]
[P01BE02, artemether, The risk or severity of methemoglobinemia can be increased when Artemether is combined with Procaine.]
[P01BE03, artesunate, The risk or severity of methemoglobinemia can be increased when Artesunate is combined with Procaine.]
[N02AF01, butorphanol, The risk or severity of adverse effects can be increased when Butorphanol is combined with Procaine.]
[J01MA09, sparfloxacin, The risk or severity of methemoglobinemia can be increased when Sparfloxacin is combined with Procaine.]
[L01FX10, olaratumab, The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Procaine.]
[S01GX07, azelastine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[J01CE04, azidocillin, The risk or severity of methemoglobinemia can be increased when Azidocillin is combined with Procaine.]
[L01XK03, rucaparib, The risk or severity of methemoglobinemia can be increased when Rucaparib is combined with Procaine.]
[S01AA26, azithromycin, The risk or severity of methemoglobinemia can be increased when Azithromycin is combined with Procaine.]
[J01CA06, bacampicillin, The risk or severity of methemoglobinemia can be increased when Bacampicillin is combined with Procaine.]
[A06AX07, plecanatide, The therapeutic efficacy of Plecanatide can be decreased when used in combination with Procaine.]
[L01EF02, ribociclib, The risk or severity of methemoglobinemia can be increased when Ribociclib is combined with Procaine.]
[R03CC12, bambuterol, Procaine may increase the neuromuscular blocking activities of Bambuterol.]
[L01FF04, avelumab, The risk or severity of methemoglobinemia can be increased when Avelumab is combined with Procaine.]
[N07XX16, deutetrabenazine, The risk or severity of adverse effects can be increased when Procaine is combined with Deutetrabenazine.]
[N02BF02, pregabalin, The therapeutic efficacy of Procaine can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, The risk or severity of methemoglobinemia can be increased when Beclamide is combined with Procaine.]
[C09AA07, benazepril, Procaine may increase the hypotensive activities of Benazepril.]
[A10BX06, benfluorex, Procaine may increase the hypoglycemic activities of Benfluorex.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Oxybuprocaine.]
[R05DB01, benzonatate, Procaine may increase the neuromuscular blocking activities of Benzonatate.]
[J01XX08, linezolid, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Linezolid.]
[L01XK02, niraparib, The risk or severity of methemoglobinemia can be increased when Niraparib is combined with Procaine.]
[L01EX10, midostaurin, The risk or severity of methemoglobinemia can be increased when Midostaurin is combined with Procaine.]
[L01FF03, durvalumab, The risk or severity of methemoglobinemia can be increased when Durvalumab is combined with Procaine.]
[L01ED04, brigatinib, The risk or severity of methemoglobinemia can be increased when Brigatinib is combined with Procaine.]
[N04BD03, safinamide, The risk or severity of adverse effects can be increased when Procaine is combined with Safinamide.]
[N07AB02, bethanechol, The risk or severity of adverse effects can be increased when Procaine is combined with Bethanechol.]
[P01AX10, fumagillin, The risk or severity of methemoglobinemia can be increased when Fumagillin is combined with Procaine.]
[J01MA23, delafloxacin, The risk or severity of methemoglobinemia can be increased when Delafloxacin is combined with Procaine.]
[B01AF04, betrixaban, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Betrixaban.]
[S01EB09, acetylcholine, The risk or severity of adverse effects can be increased when Procaine is combined with Acetylcholine.]
[L01BC06, capecitabine, The risk or severity of methemoglobinemia can be increased when Capecitabine is combined with Procaine.]
[L01XX59, enasidenib, The risk or severity of methemoglobinemia can be increased when Enasidenib is combined with Procaine.]
[L01EH02, neratinib, The risk or severity of methemoglobinemia can be increased when Neratinib is combined with Procaine.]
[L01FB01, inotuzumab ozogamicin, The risk or severity of methemoglobinemia can be increased when Inotuzumab ozogamicin is combined with Procaine.]
[L01XH01, vorinostat, The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Procaine.]
[L01EM02, copanlisib, The risk or severity of methemoglobinemia can be increased when Copanlisib is combined with Procaine.]
[L01EF03, abemaciclib, The risk or severity of methemoglobinemia can be increased when Abemaciclib is combined with Procaine.]
[C07AB07, bisoprolol, Procaine may increase the bradycardic activities of Bisoprolol.]
[R03AC17, bitolterol, The risk or severity of adverse effects can be increased when Procaine is combined with Bitolterol.]
[J05AG03, efavirenz, The risk or severity of adverse effects can be increased when Efavirenz is combined with Procaine.]
[J01DC10, cefprozil, The risk or severity of methemoglobinemia can be increased when Cefprozil is combined with Procaine.]
[C07AA17, bopindolol, Procaine may increase the bradycardic activities of Bopindolol.]
[N04AA11, bornaprine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[L01BA03, raltitrexed, The risk or severity of methemoglobinemia can be increased when Raltitrexed is combined with Procaine.]
[C01DX19, nesiritide, Procaine may increase the orthostatic hypotensive activities of Nesiritide.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Procaine is combined with Bromperidol.]
[N05CD09, brotizolam, The risk or severity of adverse effects can be increased when Procaine is combined with Brotizolam.]
[R03BA02, budesonide, The therapeutic efficacy of Procaine can be decreased when used in combination with Budesonide.]
[C04AX20, buflomedil, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Buflomedil.]
[L01XL04, tisagenlecleucel, The risk or severity of methemoglobinemia can be increased when Tisagenlecleucel is combined with Procaine.]
[L01XL03, axicabtagene ciloleucel, The risk or severity of methemoglobinemia can be increased when Axicabtagene ciloleucel is combined with Procaine.]
[N05CA03, butobarbital, The risk or severity of adverse effects can be increased when Procaine is combined with Butobarbital.]
[N06AA15, butriptyline, Procaine may increase the serotonergic activities of Butriptyline.]
[A10BJ06, semaglutide, Procaine may increase the hypoglycemic activities of Semaglutide.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Capsaicin.]
[A10BK04, ertugliflozin, Procaine may increase the hypoglycemic activities of Ertugliflozin.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Procaine is combined with Vinylbital.]
[C09AA01, captopril, Procaine may increase the hypotensive activities of Captopril.]
[S01EB02, carbachol, The risk or severity of adverse effects can be increased when Procaine is combined with Carbamoylcholine.]
[L02BB05, apalutamide, The risk or severity of methemoglobinemia can be increased when Apalutamide is combined with Procaine.]
[N03AF01, carbamazepine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Procaine.]
[A06AC08, calcium polycarbophil, The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Procaine.]
[A03AA03, camylofine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[J01CA03, carbenicillin, The risk or severity of methemoglobinemia can be increased when Carbenicillin is combined with Procaine.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Procaine is combined with Carbinoxamine.]
[C07AG02, carvedilol, Procaine may increase the bradycardic activities of Carvedilol.]
[N03AX24, cannabidiol, The metabolism of Cannabidiol can be decreased when combined with Procaine.]
[J01DE01, cefepime, The risk or severity of methemoglobinemia can be increased when Cefepime is combined with Procaine.]
[J01DD10, cefetamet, The risk or severity of methemoglobinemia can be increased when Cefetamet is combined with Procaine.]
[J01DD09, cefodizime, The risk or severity of methemoglobinemia can be increased when Cefodizime is combined with Procaine.]
[J01DC11, ceforanide, The risk or severity of methemoglobinemia can be increased when Ceforanide is combined with Procaine.]
[J01DD13, cefpodoxime, The risk or severity of methemoglobinemia can be increased when Cefpodoxime is combined with Procaine.]
[L01EC03, encorafenib, The risk or severity of methemoglobinemia can be increased when Encorafenib is combined with Procaine.]
[L01EE03, binimetinib, The risk or severity of methemoglobinemia can be increased when Binimetinib is combined with Procaine.]
[J01DD14, ceftibuten, The risk or severity of methemoglobinemia can be increased when Ceftibuten is combined with Procaine.]
[J01GB14, plazomicin, The risk or severity of methemoglobinemia can be increased when Plazomicin is combined with Procaine.]
[C07AB08, celiprolol, Procaine may increase the bradycardic activities of Celiprolol.]
[L01XX62, ivosidenib, The risk or severity of methemoglobinemia can be increased when Ivosidenib is combined with Procaine.]
[P01BA07, tafenoquine, The risk or severity of methemoglobinemia can be increased when Tafenoquine is combined with Procaine.]
[L01FX09, mogamulizumab, The risk or severity of methemoglobinemia can be increased when Mogamulizumab is combined with Procaine.]
[N03AX17, stiripentol, The risk or severity of methemoglobinemia can be increased when Stiripentol is combined with Procaine.]
[J01AA13, eravacycline, The risk or severity of methemoglobinemia can be increased when Eravacycline is combined with Procaine.]
[L01EM04, duvelisib, The risk or severity of methemoglobinemia can be increased when Duvelisib is combined with Procaine.]
[L01FF06, cemiplimab, The risk or severity of methemoglobinemia can be increased when Cemiplimab is combined with Procaine.]
[L01EB07, dacomitinib, The risk or severity of methemoglobinemia can be increased when Dacomitinib is combined with Procaine.]
[J01AA14, sarecycline, The risk or severity of methemoglobinemia can be increased when Sarecycline is combined with Procaine.]
[J01AA15, omadacycline, The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Procaine.]
[S01GX12, cetirizine, The risk or severity of adverse effects can be increased when Cetirizine is combined with Procaine.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Procaine is combined with Carbromal.]
[A10BB06, carbutamide, Procaine may increase the hypoglycemic activities of Carbutamide.]
[N01BA04, chloroprocaine, The risk or severity of adverse effects can be increased when Procaine is combined with Chloroprocaine.]
[R06AA06, chlorphenoxamine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[L01FB02, moxetumomab pasudotox, The risk or severity of methemoglobinemia can be increased when Moxetumomab pasudotox is combined with Procaine.]
[L01XK04, talazoparib, The risk or severity of methemoglobinemia can be increased when Talazoparib is combined with Procaine.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Procaine.]
[R03BB08, revefenacin, Procaine may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[L01ED05, lorlatinib, The risk or severity of methemoglobinemia can be increased when Lorlatinib is combined with Procaine.]
[L01AD01, carmustine, The risk or severity of methemoglobinemia can be increased when Carmustine is combined with Procaine.]
[L01EX12, larotrectinib, The risk or severity of methemoglobinemia can be increased when Larotrectinib is combined with Procaine.]
[L01EX13, gilteritinib, The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Procaine.]
[L01XJ03, glasdegib, The risk or severity of methemoglobinemia can be increased when Glasdegib is combined with Procaine.]
[N07XX05, amifampridine, The risk or severity of seizure can be increased when Procaine is combined with Amifampridine.]
[A06AX05, prucalopride, The therapeutic efficacy of Prucalopride can be decreased when used in combination with Procaine.]
[L01XX67, tagraxofusp, The risk or severity of methemoglobinemia can be increased when Tagraxofusp is combined with Procaine.]
[C09AA08, cilazapril, Procaine may increase the hypotensive activities of Cilazapril.]
[B01AX07, caplacizumab, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Caplacizumab.]
[B01AC23, cilostazol, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Cilostazol.]
[A03FA08, cinitapride, The metabolism of Cinitapride can be decreased when combined with Procaine.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Procaine is combined with Esketamine.]
[J01FA09, clarithromycin, The risk or severity of methemoglobinemia can be increased when Clarithromycin is combined with Procaine.]
[N06BA14, solriamfetol, The risk or severity of adverse effects can be increased when Procaine is combined with Solriamfetol.]
[N06AX29, brexanolone, The risk or severity of methemoglobinemia can be increased when Brexanolone is combined with Procaine.]
[L01EN01, erdafitinib, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Procaine.]
[N05BA09, clobazam, The risk or severity of methemoglobinemia can be increased when Clobazam is combined with Procaine.]
[J01AA11, clomocycline, The risk or severity of methemoglobinemia can be increased when Clomocycline is combined with Procaine.]
[H02AB14, cloprednol, The therapeutic efficacy of Procaine can be decreased when used in combination with Cloprednol.]
[A06AB05, castor oil, The therapeutic efficacy of Castor oil can be decreased when used in combination with Procaine.]
[N05BA22, cloxazolam, The risk or severity of adverse effects can be increased when Procaine is combined with Cloxazolam.]
[C09CA06, candesartan, Procaine may increase the hypotensive activities of Candesartan.]
[L01XX29, denileukin diftitox, The risk or severity of methemoglobinemia can be increased when Denileukin diftitox is combined with Procaine.]
[H02AB17, cortivazol, The therapeutic efficacy of Procaine can be decreased when used in combination with Cortivazol.]
[L01EM03, alpelisib, The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Procaine.]
[L01FX14, polatuzumab vedotin, The risk or severity of methemoglobinemia can be increased when Polatuzumab vedotin is combined with Procaine.]
[J01DC04, cefaclor, The risk or severity of methemoglobinemia can be increased when Cefaclor is combined with Procaine.]
[J01DB05, cefadroxil, The risk or severity of methemoglobinemia can be increased when Cefadroxil is combined with Procaine.]
[J01DC03, cefamandole, The risk or severity of methemoglobinemia can be increased when Cefamandole is combined with Procaine.]
[L01XX66, selinexor, The risk or severity of methemoglobinemia can be increased when Selinexor is combined with Procaine.]
[J01DB07, cefatrizine, The risk or severity of methemoglobinemia can be increased when Cefatrizine is combined with Procaine.]
[J01DB04, cefazolin, The risk or severity of methemoglobinemia can be increased when Cefazolin is combined with Procaine.]
[L02BB06, darolutamide, The risk or severity of methemoglobinemia can be increased when Darolutamide is combined with Procaine.]
[J01CF03, methicillin, The risk or severity of methemoglobinemia can be increased when Meticillin is combined with Procaine.]
[J01DC09, cefmetazole, The risk or severity of methemoglobinemia can be increased when Cefmetazole is combined with Procaine.]
[J01DC06, cefonicid, The risk or severity of methemoglobinemia can be increased when Cefonicid is combined with Procaine.]
[L01EX15, pexidartinib, The risk or severity of methemoglobinemia can be increased when Pexidartinib is combined with Procaine.]
[J01DD12, cefoperazone, The risk or severity of methemoglobinemia can be increased when Cefoperazone is combined with Procaine.]
[J01DD01, cefotaxime, The risk or severity of methemoglobinemia can be increased when Cefotaxime is combined with Procaine.]
[J01DC05, cefotetan, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Procaine.]
[N05AA06, cyamemazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Cyamemazine.]
[J01DC07, cefotiam, The risk or severity of methemoglobinemia can be increased when Cefotiam is combined with Procaine.]
[J01DC01, cefoxitin, The risk or severity of methemoglobinemia can be increased when Cefoxitin is combined with Procaine.]
[J01DD03, cefsulodin, The risk or severity of methemoglobinemia can be increased when Cefsulodin is combined with Procaine.]
[J01DD02, ceftazidime, The risk or severity of methemoglobinemia can be increased when Ceftazidime is combined with Procaine.]
[C03BX03, cicletanine, Procaine may increase the hypotensive activities of Cicletanine.]
[J01DD07, ceftizoxime, The risk or severity of methemoglobinemia can be increased when Ceftizoxime is combined with Procaine.]
[J01DD04, ceftriaxone, The risk or severity of methemoglobinemia can be increased when Ceftriaxone is combined with Procaine.]
[S01AA27, cefuroxime, The risk or severity of methemoglobinemia can be increased when Cefuroxime is combined with Procaine.]
[M03BX08, cyclobenzaprine, Cyclobenzaprine may increase the serotonergic activities of Procaine.]
[L01EJ02, fedratinib, The risk or severity of methemoglobinemia can be increased when Fedratinib is combined with Procaine.]
[L01EX14, entrectinib, The risk or severity of methemoglobinemia can be increased when Entrectinib is combined with Procaine.]
[J01XX12, lefamulin, The risk or severity of methemoglobinemia can be increased when Lefamulin is combined with Procaine.]
[C03AA09, cyclothiazide, Procaine may increase the hypotensive activities of Cyclothiazide.]
[G04BE04, yohimbine, The risk or severity of adverse effects can be increased when Procaine is combined with Yohimbine.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Procaine is combined with Insulin pork.]
[A06AB03, danthron, The therapeutic efficacy of Dantron can be decreased when used in combination with Procaine.]
[J01XX09, daptomycin, The risk or severity of methemoglobinemia can be increased when Daptomycin is combined with Procaine.]
[J01DB01, cephalexin, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Procaine.]
[J01DB02, cephaloridine, The risk or severity of methemoglobinemia can be increased when Cefaloridine is combined with Procaine.]
[J01DB03, cephalothin, The risk or severity of methemoglobinemia can be increased when Cefalotin is combined with Procaine.]
[J01DB08, cephapirin, The risk or severity of methemoglobinemia can be increased when Cefapirin is combined with Procaine.]
[J01DB09, cephradine, The risk or severity of methemoglobinemia can be increased when Cefradine is combined with Procaine.]
[H02AB13, deflazacort, The therapeutic efficacy of Procaine can be decreased when used in combination with Deflazacort.]
[L01FD01, trastuzumab, The risk or severity of methemoglobinemia can be increased when Trastuzumab is combined with Procaine.]
[L01FD03, ado-trastuzumab emtansine, The risk or severity of methemoglobinemia can be increased when Trastuzumab emtansine is combined with Procaine.]
[L01FD04, trastuzumab deruxtecan, The risk or severity of methemoglobinemia can be increased when Trastuzumab deruxtecan is combined with Procaine.]
[N02CC08, lasmiditan, The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Procaine.]
[L01EL03, zanubrutinib, The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Procaine.]
[N03AX25, cenobamate, The risk or severity of methemoglobinemia can be increased when Cenobamate is combined with Procaine.]
[L01FX13, enfortumab vedotin, The risk or severity of methemoglobinemia can be increased when Enfortumab vedotin is combined with Procaine.]
[R06AB06, dexbrompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Procaine.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Dezocine is combined with Procaine.]
[L01XX10, masoprocol, The risk or severity of methemoglobinemia can be increased when Masoprocol is combined with Procaine.]
[N05CM21, lemborexant, The risk or severity of adverse effects can be increased when Procaine is combined with Lemborexant.]
[N05AD10, lumateperone, The risk or severity of adverse effects can be increased when Procaine is combined with Lumateperone.]
[L01FC02, isatuximab, The risk or severity of methemoglobinemia can be increased when Isatuximab is combined with Procaine.]
[S01AE06, gatifloxacin, The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Procaine.]
[N02CC07, frovatriptan, The risk or severity of adverse effects can be increased when Procaine is combined with Frovatriptan.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Procaine is combined with Dichloralphenazone.]
[L01EE04, selumetinib, The risk or severity of methemoglobinemia can be increased when Selumetinib is combined with Procaine.]
[G03DB08, dienogest, The risk or severity of methemoglobinemia can be increased when Dienogest is combined with Procaine.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Procaine is combined with Difenoxin.]
[L01XD01, porfimer sodium, The risk or severity of methemoglobinemia can be increased when Porfimer sodium is combined with Procaine.]
[N02AA08, dihydrocodeine, The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Procaine.]
[N02CC06, eletriptan, The risk or severity of adverse effects can be increased when Eletriptan is combined with Procaine.]
[L01XF03, bexarotene, The risk or severity of methemoglobinemia can be increased when Bexarotene is combined with Procaine.]
[C08CA16, clevidipine, Procaine may increase the neuromuscular blocking activities of Clevidipine.]
[N03AG02, dipropylacetamide, The risk or severity of methemoglobinemia can be increased when Valpromide is combined with Procaine.]
[J01FA13, dirithromycin, The risk or severity of methemoglobinemia can be increased when Dirithromycin is combined with Procaine.]
[L01AA02, chlorambucil, The risk or severity of methemoglobinemia can be increased when Chlorambucil is combined with Procaine.]
[S03AA08, chloramphenicol, The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Procaine.]
[N05BA02, chlordiazepoxide, The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Procaine.]
[C02AA06, methoserpidine, Procaine may increase the hypotensive activities of Methoserpidine.]
[L01EN02, pemigatinib, The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Procaine.]
[L01FX17, sacituzumab govitecan, The risk or severity of methemoglobinemia can be increased when Sacituzumab govitecan is combined with Procaine.]
[L01EH03, tucatinib, The risk or severity of methemoglobinemia can be increased when Tucatinib is combined with Procaine.]
[A03AA08, dihexyverine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[L01EX17, capmatinib, The risk or severity of methemoglobinemia can be increased when Capmatinib is combined with Procaine.]
[N04BX04, opicapone, Procaine may increase the orthostatic hypotensive activities of Opicapone.]
[D07XB03, fluprednidene, The therapeutic efficacy of Procaine can be decreased when used in combination with Fluprednidene.]
[P01BE01, artemisinin, The risk or severity of methemoglobinemia can be increased when Artemisinin is combined with Procaine.]
[G04BD09, trospium, Procaine may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[L01EX19, ripretinib, The risk or severity of methemoglobinemia can be increased when Ripretinib is combined with Procaine.]
[L01EX22, selpercatinib, The risk or severity of methemoglobinemia can be increased when Selpercatinib is combined with Procaine.]
[B01AE02, lepirudin, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Lepirudin.]
[N05CM02, chlormethiazole, The risk or severity of methemoglobinemia can be increased when Clomethiazole is combined with Procaine.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Procaine is combined with Chlormezanone.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Dyclonine is combined with Procaine.]
[L01XX69, lurbinectedin, The risk or severity of methemoglobinemia can be increased when Lurbinectedin is combined with Procaine.]
[C08CA17, levamlodipine, Procaine may increase the hypotensive activities of Levamlodipine.]
[P01BB01, proguanil, The risk or severity of methemoglobinemia can be increased when Proguanil is combined with Procaine.]
[N05CD14, remimazolam, The risk or severity of sedation can be increased when Procaine is combined with Remimazolam.]
[L01FX12, tafasitamab, The risk or severity of methemoglobinemia can be increased when Tafasitamab is combined with Procaine.]
[L01XL06, brexucabtagene autoleucel, The risk or severity of methemoglobinemia can be increased when Brexucabtagene autoleucel is combined with Procaine.]
[L01DB04, aclarubicin, The risk or severity of methemoglobinemia can be increased when Aclarubicin is combined with Procaine.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Procaine is combined with Oliceridine.]
[P01BA01, chloroquine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Procaine.]
[L01EX23, pralsetinib, The risk or severity of methemoglobinemia can be increased when Pralsetinib is combined with Procaine.]
[C03AA04, chlorothiazide, Procaine may increase the hypotensive activities of Chlorothiazide.]
[G03CA06, chlorotrianisene, The risk or severity of methemoglobinemia can be increased when Chlorotrianisene is combined with Procaine.]
[R06AB04, chlorpheniramine, The risk or severity of adverse effects can be increased when Procaine is combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Chlorpromazine.]
[A10BB02, chlorpropamide, Procaine may increase the hypoglycemic activities of Chlorpropamide.]
[N05AF03, chlorprothixene, Procaine may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.]
[S01AA02, chlortetracycline, The risk or severity of methemoglobinemia can be increased when Chlortetracycline is combined with Procaine.]
[C03BA04, chlorthalidone, Procaine may increase the hypotensive activities of Chlorthalidone.]
[M03BB03, chlorzoxazone, The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Procaine.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Procaine is combined with Etifoxine.]
[N06BX18, vinpocetine, The risk or severity of methemoglobinemia can be increased when Vinpocetine is combined with Procaine.]
[N05BA18, ethyl loflazepate, The risk or severity of adverse effects can be increased when Procaine is combined with Ethyl loflazepate.]
[L01BB05, fludarabine, The risk or severity of methemoglobinemia can be increased when Fludarabine is combined with Procaine.]
[L01FD06, margetuximab, The risk or severity of methemoglobinemia can be increased when Margetuximab is combined with Procaine.]
[C01DX22, vericiguat, Procaine may increase the orthostatic hypotensive activities of Vericiguat.]
[L01EX21, tepotinib, The risk or severity of methemoglobinemia can be increased when Tepotinib is combined with Procaine.]
[L01EX25, umbralisib, The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Procaine.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Procaine is combined with Febarbamate.]
[N03AX10, felbamate, The risk or severity of methemoglobinemia can be increased when Felbamate is combined with Procaine.]
[C01CA19, fenoldopam, Procaine may increase the hypotensive activities of Fenoldopam.]
[J01DD08, cefixime, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Procaine.]
[J01DD15, cefdinir, The risk or severity of methemoglobinemia can be increased when Cefdinir is combined with Procaine.]
[J01MB07, flumequine, The risk or severity of methemoglobinemia can be increased when Flumequine is combined with Procaine.]
[R03BA03, flunisolide, The therapeutic efficacy of Procaine can be decreased when used in combination with Flunisolide.]
[S02BA08, fluocinolone acetonide, The therapeutic efficacy of Procaine can be decreased when used in combination with Fluocinolone acetonide.]
[R03CC15, formoterol, The risk or severity of adverse effects can be increased when Procaine is combined with Formoterol.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Procaine is combined with Insulin human.]
[S01LA08, bevacizumab, The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Procaine.]
[L01EK03, tivozanib, The risk or severity of methemoglobinemia can be increased when Tivozanib is combined with Procaine.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Trichloroethylene is combined with Procaine.]
[H04AA02, dasiglucagon, Procaine may increase the hypotensive activities of Dasiglucagon.]
[L01XL07, idecabtagene vicleucel, The risk or severity of methemoglobinemia can be increased when Idecabtagene vicleucel is combined with Procaine.]
[L01FF07, dostarlimab, The risk or severity of methemoglobinemia can be increased when Dostarlimab is combined with Procaine.]
[L01FX22, loncastuximab tesirine, The risk or severity of methemoglobinemia can be increased when Loncastuximab tesirine is combined with Procaine.]
[R02AB03, fusafungin, The risk or severity of methemoglobinemia can be increased when Fusafungine is combined with Procaine.]
[N02BF01, gabapentin, The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Procaine.]
[J01MB06, cinoxacin, The risk or severity of methemoglobinemia can be increased when Cinoxacin is combined with Procaine.]
[L01XX73, sotorasib, The risk or severity of methemoglobinemia can be increased when Sotorasib is combined with Procaine.]
[L01EN03, infigratinib, The risk or severity of methemoglobinemia can be increased when Infigratinib is combined with Procaine.]
[S03AA07, ciprofloxacin, The risk or severity of methemoglobinemia can be increased when Ciprofloxacin is combined with Procaine.]
[L01XA01, cisplatin, The risk or severity of methemoglobinemia can be increased when Cisplatin is combined with Procaine.]
[N06AB04, citalopram, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Citalopram.]
[L01XX74, belzutifan, The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Procaine.]
[L01FX23, tisotumab vedotin, The risk or severity of methemoglobinemia can be increased when Tisotumab vedotin is combined with Procaine.]
[V09IA09, technetium Tc 99m tilmanocept, Procaine may decrease effectiveness of Technetium Tc-99m tilmanocept as a diagnostic agent.]
[R06AA04, clemastine, Procaine may increase the anticholinergic activities of Clemastine.]
[A10BB12, glimepiride, Procaine may increase the hypoglycemic activities of Glimepiride.]
[A10BB08, gliquidone, Procaine may increase the hypoglycemic activities of Gliquidone.]
[R03CC13, clenbuterol, The risk or severity of adverse effects can be increased when Procaine is combined with Clenbuterol.]
[J01FF01, clindamycin, The risk or severity of methemoglobinemia can be increased when Clindamycin is combined with Procaine.]
[N06AX25, St. John's wort extract, The risk or severity of adverse effects can be increased when Procaine is combined with St. John's Wort.]
[L01EA06, asciminib, The risk or severity of methemoglobinemia can be increased when Asciminib is combined with Procaine.]
[L02BG06, exemestane, The risk or severity of methemoglobinemia can be increased when Exemestane is combined with Procaine.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Procaine.]
[L01XX75, tebentafusp, The risk or severity of methemoglobinemia can be increased when Tebentafusp is combined with Procaine.]
[J04BA01, clofazimine, The risk or severity of methemoglobinemia can be increased when Clofazimine is combined with Procaine.]
[B01AD11, tenecteplase, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Tenecteplase.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Levobupivacaine.]
[N06AA04, clomipramine, Procaine may increase the serotonergic activities of Clomipramine.]
[N03AE01, clonazepam, The risk or severity of methemoglobinemia can be increased when Clonazepam is combined with Procaine.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Procaine.]
[A10BX16, tirzepatide, Procaine may increase the hypoglycemic activities of Tirzepatide.]
[L01FX20, tremelimumab, The risk or severity of methemoglobinemia can be increased when Tremelimumab is combined with Procaine.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Procaine is combined with Clothiapine.]
[N05BA21, clotiazepam, The risk or severity of adverse effects can be increased when Procaine is combined with Clotiazepam.]
[A04AA01, ondansetron, The risk or severity of adverse effects can be increased when Procaine is combined with Ondansetron.]
[A04AA02, granisetron, The risk or severity of adverse effects can be increased when Procaine is combined with Granisetron.]
[J01CF02, cloxacillin, The risk or severity of methemoglobinemia can be increased when Cloxacillin is combined with Procaine.]
[L01XX77, adagrasib, The risk or severity of methemoglobinemia can be increased when Adagrasib is combined with Procaine.]
[N05AH02, clozapine, Procaine may increase the orthostatic hypotensive activities of Clozapine.]
[L01EN04, futibatinib, The risk or severity of methemoglobinemia can be increased when Futibatinib is combined with Procaine.]
[L01FE02, panitumumab, The risk or severity of methemoglobinemia can be increased when Panitumumab is combined with Procaine.]
[A10BX01, guar gum, Procaine may increase the hypoglycemic activities of Guar gum.]
[A10BK06, sotagliflozin, Procaine may increase the hypoglycemic activities of Sotagliflozin.]
[J01GB12, arbekacin, The risk or severity of methemoglobinemia can be increased when Arbekacin is combined with Procaine.]
[N05BA13, halazepam, The risk or severity of adverse effects can be increased when Procaine is combined with Halazepam.]
[L01EX11, quizartinib, The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Procaine.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Cocaine.]
[C02KB01, metyrosine, Procaine may increase the sedative activities of Metyrosine.]
[R05DA04, codeine, The risk or severity of adverse effects can be increased when Codeine is combined with Procaine.]
[J01CA18, hetacillin, The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Procaine.]
[M03AC05, hexafluorenium, Hexafluronium may increase the neuromuscular blocking activities of Procaine.]
[A03AB10, hexocyclium, Procaine may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[J01XX04, spectinomycin, The risk or severity of methemoglobinemia can be increased when Spectinomycin is combined with Procaine.]
[S01FA05, homatropine, The risk or severity of adverse effects can be increased when Procaine is combined with Homatropine.]
[A03BB06, homatropine methylbromide, Procaine may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[J01XB01, colistin, The risk or severity of methemoglobinemia can be increased when Colistin is combined with Procaine.]
[L01XX40, omacetaxine mepesuccinate, The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Procaine.]
[J01DE02, cefpirome, The risk or severity of methemoglobinemia can be increased when Cefpirome is combined with Procaine.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Desflurane is combined with Procaine.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Procaine is combined with Tropisetron.]
[C04AX28, ifenprodil, The risk or severity of methemoglobinemia can be increased when Ifenprodil is combined with Procaine.]
[A10BX03, nateglinide, Procaine may increase the hypoglycemic activities of Nateglinide.]
[H01AC03, mecasermin, Procaine may increase the hypoglycemic activities of Mecasermin.]
[L01BB07, nelarabine, The risk or severity of methemoglobinemia can be increased when Nelarabine is combined with Procaine.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Procaine is combined with Insulin glargine.]
[J01FA15, telithromycin, The risk or severity of methemoglobinemia can be increased when Telithromycin is combined with Procaine.]
[R03BA08, ciclesonide, The therapeutic efficacy of Procaine can be decreased when used in combination with Ciclesonide.]
[B01AC10, indobufen, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Indobufen.]
[R06AX27, desloratadine, The risk or severity of adverse effects can be increased when Procaine is combined with Desloratadine.]
[H01AX01, pegvisomant, Pegvisomant may increase the neuromuscular blocking activities of Procaine.]
[A03AX10, isometheptene, Procaine may increase the sympathomimetic activities of Isometheptene.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Procaine.]
[B01AB12, bemiparin, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Bemiparin.]
[N05BA10, ketazolam, The risk or severity of adverse effects can be increased when Procaine is combined with Ketazolam.]
[L02BA03, fulvestrant, The risk or severity of methemoglobinemia can be increased when Fulvestrant is combined with Procaine.]
[L01EA01, imatinib, The risk or severity of methemoglobinemia can be increased when Imatinib is combined with Procaine.]
[C08CA09, lacidipine, Procaine may increase the hypotensive activities of Lacidipine.]
[V03AF07, rasburicase, The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Procaine.]
[A06AD12, lactitol, The therapeutic efficacy of Lactitol can be decreased when used in combination with Procaine.]
[N03AX09, lamotrigine, The risk or severity of methemoglobinemia can be increased when Lamotrigine is combined with Procaine.]
[S01BA03, cortisone, The therapeutic efficacy of Procaine can be decreased when used in combination with Cortisone.]
[N07BC04, lofexidine, The therapeutic efficacy of Procaine can be increased when used in combination with Lofexidine.]
[S01AE04, lomefloxacin, The risk or severity of methemoglobinemia can be increased when Lomefloxacin is combined with Procaine.]
[R06AX13, loratadine, Procaine may increase the anticholinergic activities of Loratadine.]
[N05CD06, lormetazepam, The risk or severity of adverse effects can be increased when Procaine is combined with Lormetazepam.]
[J01DC08, loracarbef, The risk or severity of methemoglobinemia can be increased when Loracarbef is combined with Procaine.]
[C09AA03, lisinopril, Procaine may increase the hypotensive activities of Lisinopril.]
[A06AD01, magnesium carbonate, The therapeutic efficacy of Magnesium carbonate can be decreased when used in combination with Procaine.]
[C08CA11, manidipine, Procaine may increase the hypotensive activities of Manidipine.]
[A03AA04, mebeverine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[D10AF04, meclocycline, The risk or severity of methemoglobinemia can be increased when Meclocycline is combined with Procaine.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Procaine is combined with Medifoxamine.]
[C07AA14, mepindolol, Procaine may increase the bradycardic activities of Mepindolol.]
[H02AB15, meprednisone, The therapeutic efficacy of Procaine can be decreased when used in combination with Meprednisone.]
[R06AD07, mequitazine, Procaine may increase the anticholinergic activities of Mequitazine.]
[J01DH02, meropenem, The risk or severity of methemoglobinemia can be increased when Meropenem is combined with Procaine.]
[J01CA14, methampicillin, The risk or severity of methemoglobinemia can be increased when Metampicillin is combined with Procaine.]
[N04AA03, methixene, Procaine may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[R03CB02, methoxyphenamine, Procaine may increase the hypertensive activities of Methoxyphenamine.]
[R06AE03, cyclizine, The risk or severity of adverse effects can be increased when Procaine is combined with Cyclizine.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Procaine is combined with Cyclobarbital.]
[C03DA04, eplerenone, Procaine may increase the hypotensive activities of Eplerenone.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Procaine is combined with Melperone.]
[S01AA22, micronomicin, The risk or severity of methemoglobinemia can be increased when Micronomicin is combined with Procaine.]
[C03AA07, cyclopenthiazide, Procaine may increase the hypotensive activities of Cyclopenthiazide.]
[J01FA03, midecamycin, The risk or severity of methemoglobinemia can be increased when Midecamycin is combined with Procaine.]
[A10BF02, miglitol, Procaine may increase the hypoglycemic activities of Miglitol.]
[S01FA04, cyclopentolate, The risk or severity of adverse effects can be increased when Procaine is combined with Cyclopentolate.]
[L01AA01, cyclophosphamide, The risk or severity of methemoglobinemia can be increased when Cyclophosphamide is combined with Procaine.]
[N06AX07, minaprine, The risk or severity of adverse effects can be increased when Procaine is combined with Minaprine.]
[J04AB01, cycloserine, The risk or severity of methemoglobinemia can be increased when Cycloserine is combined with Procaine.]
[N06AG02, moclobemide, The risk or severity of adverse effects can be increased when Procaine is combined with Moclobemide.]
[R06AX02, cyproheptadine, Procaine may increase the anticholinergic activities of Cyproheptadine.]
[C09AA13, moexipril, Procaine may increase the hypotensive activities of Moexipril.]
[C03XA02, conivaptan, Procaine may increase the orthostatic hypotensive activities of Conivaptan.]
[C02AC05, moxonidine, Procaine may increase the hypotensive activities of Moxonidine.]
[L01BC01, cytarabine, The risk or severity of methemoglobinemia can be increased when Cytarabine is combined with Procaine.]
[L01AX04, dacarbazine, The risk or severity of methemoglobinemia can be increased when Dacarbazine is combined with Procaine.]
[L01DA01, dactinomycin, The risk or severity of methemoglobinemia can be increased when Dactinomycin is combined with Procaine.]
[M03CA01, dantrolene, The risk or severity of adverse effects can be increased when Procaine is combined with Dantrolene.]
[J04BA02, dapsone, The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Procaine.]
[L01DB02, daunorubicin, The risk or severity of methemoglobinemia can be increased when Daunorubicin is combined with Procaine.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Procaine is combined with Deanol.]
[C02CC04, debrisoquin, Procaine may increase the hypotensive activities of Debrisoquine.]
[L01DB09, valrubicin, The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Procaine.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Procaine.]
[J01AA01, demeclocycline, The risk or severity of methemoglobinemia can be increased when Demeclocycline is combined with Procaine.]
[N05BA16, nordazepam, The risk or severity of adverse effects can be increased when Procaine is combined with Nordazepam.]
[C07AB12, nebivolol, Procaine may increase the bradycardic activities of Nebivolol.]
[N06AX06, nefazodone, Procaine may increase the serotonergic activities of Nefazodone.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Procaine is combined with Niaprazine.]
[C01DX16, nicorandil, Procaine may increase the hypotensive activities of Nicorandil.]
[L02BB02, nilutamide, The risk or severity of methemoglobinemia can be increased when Nilutamide is combined with Procaine.]
[L01FE01, cetuximab, The risk or severity of methemoglobinemia can be increased when Cetuximab is combined with Procaine.]
[N03AG06, tiagabine, The risk or severity of methemoglobinemia can be increased when Tiagabine is combined with Procaine.]
[M03AC11, cisatracurium, Procaine may increase the neuromuscular blocking activities of Cisatracurium.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Normethadone is combined with Procaine.]
[B01AX05, fondaparinux, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Fondaparinux.]
[N06AB10, escitalopram, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Escitalopram.]
[G04BD08, solifenacin, Procaine may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.]
[R02AA02, dequalinium, The risk or severity of methemoglobinemia can be increased when Dequalinium is combined with Procaine.]
[N06AA01, desipramine, Procaine may increase the serotonergic activities of Desipramine.]
[D07XC02, desoximetasone, The therapeutic efficacy of Procaine can be decreased when used in combination with Desoximetasone.]
[H02AA03, desoxycorticosterone, The therapeutic efficacy of Procaine can be decreased when used in combination with Desoxycortone.]
[J01DH03, ertapenem, The risk or severity of methemoglobinemia can be increased when Ertapenem is combined with Procaine.]
[C09XA02, aliskiren, Procaine may increase the hypotensive activities of Aliskiren.]
[L01XA03, oxaliplatin, The risk or severity of methemoglobinemia can be increased when Oxaliplatin is combined with Procaine.]
[N03AF02, oxcarbazepine, The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Procaine.]
[S03BA01, dexamethasone, The risk or severity of methemoglobinemia can be increased when Dexamethasone is combined with Procaine.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Procaine is combined with Oxiracetam.]
[N04AA08, dexetimide, Procaine may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, Procaine may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.]
[A08AA04, dexfenfluramine, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Dexfenfluramine.]
[A03AA01, oxyphencyclimine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[L01EB01, gefitinib, The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Procaine.]
[N06BA02, dextroamphetamine, Procaine may increase the hypertensive activities of Amphetamine.]
[R05DA09, dextromethorphan, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Dextromethorphan.]
[N03AC01, paramethadione, The risk or severity of methemoglobinemia can be increased when Paramethadione is combined with Procaine.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Dextromoramide is combined with Procaine.]
[N06AB05, paroxetine, Procaine may increase the serotonergic activities of Paroxetine.]
[B01AC04, clopidogrel, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Clopidogrel.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Diamorphine is combined with Procaine.]
[N05BA01, diazepam, The risk or severity of methemoglobinemia can be increased when Diazepam is combined with Procaine.]
[N03AX07, phenacemide, The risk or severity of methemoglobinemia can be increased when Phenacemide is combined with Procaine.]
[V03AH01, diazoxide, Procaine may increase the hypotensive activities of Diazoxide.]
[J01CE05, phenethicillin, The risk or severity of methemoglobinemia can be increased when Pheneticillin is combined with Procaine.]
[S01AA29, dibekacin, The risk or severity of methemoglobinemia can be increased when Dibekacin is combined with Procaine.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Phenol.]
[N03AD02, phensuximide, The risk or severity of methemoglobinemia can be increased when Phensuximide is combined with Procaine.]
[N06AA08, dibenzepin, Procaine may increase the serotonergic activities of Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Cinchocaine is combined with Procaine.]
[R05DA08, pholcodine, Pholcodine may increase the serotonergic activities of Procaine.]
[S01EC02, dichlorphenamide, Procaine may increase the orthostatic hypotensive activities of Diclofenamide.]
[J01CF01, dicloxacillin, The risk or severity of methemoglobinemia can be increased when Dicloxacillin is combined with Procaine.]
[A03AA07, dicyclomine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[C02DG01, pinacidil, Procaine may increase the hypotensive activities of Pinacidil.]
[A10BG03, pioglitazone, Procaine may increase the hypoglycemic activities of Pioglitazone.]
[N05AD05, pipamperone, Procaine may increase the orthostatic hypotensive activities of Pipamperone.]
[A03AB14, pipenzolate, Procaine may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01DC04, ixabepilone, The risk or severity of methemoglobinemia can be increased when Ixabepilone is combined with Procaine.]
[L01EB02, erlotinib, The risk or severity of methemoglobinemia can be increased when Erlotinib is combined with Procaine.]
[L01DB08, pirarubicin, The risk or severity of methemoglobinemia can be increased when Pirarubicin is combined with Procaine.]
[R03CC07, pirbuterol, The risk or severity of adverse effects can be increased when Procaine is combined with Pirbuterol.]
[P02CB02, diethylcarbamazine, Diethylcarbamazine may increase the neuromuscular blocking activities of Procaine.]
[A08AA03, diethylpropion, The risk or severity of adverse effects can be increased when Procaine is combined with Diethylpropion.]
[C08CA03, isradipine, Procaine may increase the hypotensive activities of Isradipine.]
[D07XC04, diflucortolone, The therapeutic efficacy of Procaine can be decreased when used in combination with Difluocortolone.]
[A03AB11, poldine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[C02DB01, dihydralazine, Procaine may increase the hypotensive activities of Dihydralazine.]
[L01XX24, pegaspargase, The risk or severity of methemoglobinemia can be increased when Pegaspargase is combined with Procaine.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be decreased when combined with Procaine.]
[N02AA03, hydromorphone, Procaine may increase the serotonergic activities of Hydromorphone.]
[L04AX04, lenalidomide, The risk or severity of methemoglobinemia can be increased when Lenalidomide is combined with Procaine.]
[B01AC21, treprostinil, Procaine may increase the hypotensive activities of Treprostinil.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Pramocaine.]
[C08DB01, diltiazem, Procaine may increase the hypotensive activities of Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Procaine is combined with Dimenhydrinate.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Procaine is combined with Pridinol.]
[R06AB03, dimethindene, Procaine may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[R03CC08, procaterol, The risk or severity of adverse effects can be increased when Procaine is combined with Procaterol.]
[N03AG05, progabide, The risk or severity of methemoglobinemia can be increased when Progabide is combined with Procaine.]
[J01CE03, propicillin, The risk or severity of methemoglobinemia can be increased when Propicillin is combined with Procaine.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of adverse effects can be increased when Procaine is combined with Diphenhydramine.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Procaine is combined with Diphenoxylate.]
[N05CD10, quazepam, The risk or severity of adverse effects can be increased when Procaine is combined with Quazepam.]
[C09AA06, quinapril, Procaine may increase the hypotensive activities of Quinapril.]
[B01AC07, dipyridamole, The therapeutic efficacy of Procaine can be decreased when used in combination with Dipyridamole.]
[N06BA11, dexmethylphenidate, Procaine may increase the hypertensive activities of Dexmethylphenidate.]
[B01AD10, drotrecogin alfa, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Drotrecogin alfa.]
[N06AA23, quinupramine, Procaine may increase the serotonergic activities of Quinupramine.]
[A03FA02, cisapride, The risk or severity of adverse effects can be increased when Cisapride is combined with Procaine.]
[C09AA05, ramipril, Procaine may increase the hypotensive activities of Ramipril.]
[S01XA23, sirolimus, The risk or severity of methemoglobinemia can be increased when Sirolimus is combined with Procaine.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Remoxipride is combined with Procaine.]
[C01BA03, disopyramide, Procaine may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.]
[N07AA03, distigmine, Distigmine may increase the neuromuscular blocking activities of Procaine.]
[S02AA12, rifamycin SV, The risk or severity of methemoglobinemia can be increased when Rifamycin is combined with Procaine.]
[J04AB05, rifapentine, The risk or severity of methemoglobinemia can be increased when Rifapentine is combined with Procaine.]
[D06AX11, rifaximin, The risk or severity of methemoglobinemia can be increased when Rifaximin is combined with Procaine.]
[N07XX02, riluzole, The risk or severity of methemoglobinemia can be increased when Riluzole is combined with Procaine.]
[N05AX08, risperidone, The risk or severity of adverse effects can be increased when Procaine is combined with Risperidone.]
[R06AE09, levocetirizine, The risk or severity of adverse effects can be increased when Procaine is combined with Levocetirizine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Ropivacaine is combined with Procaine.]
[J01MB01, rosoxacin, The risk or severity of methemoglobinemia can be increased when Rosoxacin is combined with Procaine.]
[L01EX01, sunitinib, The risk or severity of methemoglobinemia can be increased when Sunitinib is combined with Procaine.]
[L01XG01, bortezomib, The risk or severity of methemoglobinemia can be increased when Bortezomib is combined with Procaine.]
[G04BE08, tadalafil, Procaine may increase the hypotensive activities of Tadalafil.]
[C02KX02, ambrisentan, Procaine may increase the hypotensive activities of Ambrisentan.]
[R03AC12, salmeterol, The risk or severity of adverse effects can be increased when Procaine is combined with Salmeterol.]
[C01CA07, dobutamine, Procaine may increase the hypertensive activities of Dobutamine.]
[A03FA03, domperidone, The risk or severity of QTc prolongation, torsade de pointes, and cardiotoxicity can be increased when Procaine is combined with Domperidone.]
[N06AA16, dothiepin, Procaine may increase the serotonergic activities of Dosulepin.]
[R07AB01, doxapram, Procaine may increase the hypertensive activities of Doxapram.]
[N06AA12, doxepin, Procaine may increase the serotonergic activities of Doxepin.]
[A06AB06, sennosides, USP, The therapeutic efficacy of Sennosides can be decreased when used in combination with Procaine.]
[L01DB01, doxorubicin, The risk or severity of methemoglobinemia can be increased when Doxorubicin is combined with Procaine.]
[J01AA02, doxycycline, The risk or severity of methemoglobinemia can be increased when Doxycycline is combined with Procaine.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Procaine.]
[N06AB06, sertraline, The risk or severity of serotonin syndrome can be increased when Sertraline is combined with Procaine.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Sevoflurane is combined with Procaine.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Procaine.]
[A08AA10, sibutramine, Procaine may increase the serotonergic activities of Sibutramine.]
[V03AG05, sodium phosphate, The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Procaine.]
[A12CA02, sodium sulfate, The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Procaine.]
[C09AA11, spirapril, Procaine may increase the hypotensive activities of Spirapril.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Procaine is combined with Sultopride.]
[N02CC01, sumatriptan, The metabolism of Sumatriptan can be decreased when combined with Procaine.]
[V04CX07, edrophonium, Edrophonium may increase the neuromuscular blocking activities of Procaine.]
[C07AB13, talinolol, Procaine may increase the bradycardic activities of Talinolol.]
[H01AA01, corticotropin, The therapeutic efficacy of Procaine can be decreased when used in combination with Corticotropin.]
[J01MA05, temafloxacin, The risk or severity of methemoglobinemia can be increased when Temafloxacin is combined with Procaine.]
[J01CA17, temocillin, The risk or severity of methemoglobinemia can be increased when Temocillin is combined with Procaine.]
[L01AX03, temozolomide, The risk or severity of methemoglobinemia can be increased when Temozolomide is combined with Procaine.]
[G04CA03, terazosin, Procaine may increase the hypotensive activities of Terazosin.]
[C07AA16, tertatolol, Procaine may increase the bradycardic activities of Tertatolol.]
[S01GA02, tetrahydrozoline, The risk or severity of hypertension can be increased when Procaine is combined with Tetryzoline.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Procaine is combined with Tetrazepam.]
[M03BX05, thiocolchicoside, The risk or severity of adverse effects can be increased when Procaine is combined with Thiocolchicoside.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Procaine is combined with Thiopropazate.]
[G04BD01, emepronium, Procaine may increase the central nervous system depressant (CNS depressant) activities of Emepronium.]
[N06AX14, tianeptine, The risk or severity of adverse effects can be increased when Tianeptine is combined with Procaine.]
[C09AA02, enalapril, Procaine may increase the hypotensive activities of Enalapril.]
[N05BA23, tofisopam, The risk or severity of adverse effects can be increased when Procaine is combined with Tofisopam.]
[N06AG03, toloxatone, The risk or severity of adverse effects can be increased when Procaine is combined with Toloxatone.]
[N06BA09, atomoxetine, The risk or severity of adverse effects can be increased when Procaine is combined with Atomoxetine.]
[N03AX11, topiramate, The risk or severity of methemoglobinemia can be increased when Topiramate is combined with Procaine.]
[L02BA02, toremifene, The risk or severity of methemoglobinemia can be increased when Toremifene is combined with Procaine.]
[C03CA04, torsemide, Procaine may increase the hypotensive activities of Torasemide.]
[J01AA12, tigecycline, The risk or severity of methemoglobinemia can be increased when Tigecycline is combined with Procaine.]
[C09AA10, trandolapril, Procaine may increase the hypotensive activities of Trandolapril.]
[L01AB02, treosulfan, The risk or severity of methemoglobinemia can be increased when Treosulfan is combined with Procaine.]
[N05CD11, triazulenone, The risk or severity of adverse effects can be increased when Procaine is combined with Loprazolam.]
[N05CC01, chloral hydrate, The risk or severity of adverse effects can be increased when Procaine is combined with Chloral hydrate.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Procaine is combined with Triclofos.]
[A03AB08, tridihexethyl, Procaine may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[B01AC18, triflusal, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Triflusal.]
[H02CA01, trilostane, The risk or severity of methemoglobinemia can be increased when Trilostane is combined with Procaine.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Procaine.]
[L02AE04, triptorelin, The risk or severity of methemoglobinemia can be increased when Triptorelin is combined with Procaine.]
[L01AA07, trofosfamide, The risk or severity of methemoglobinemia can be increased when Trofosfamide is combined with Procaine.]
[N04AA12, tropatepine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[C05CA04, troxerutin, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Troxerutin.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Procaine.]
[C02CA06, urapidil, Procaine may increase the hypotensive activities of Urapidil.]
[J01MA04, enoxacin, The risk or severity of methemoglobinemia can be increased when Enoxacin is combined with Procaine.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Procaine is combined with Veralipride.]
[L01CA04, vinorelbine, The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Procaine.]
[S01FB02, ephedrine, Procaine may increase the neuromuscular blocking activities of Ephedrine.]
[S01GX10, epinastine, The risk or severity of adverse effects can be increased when Procaine is combined with Epinastine.]
[N06AX16, venlafaxine, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Venlafaxine.]
[S01GA03, xylometazoline, Procaine may increase the hypertensive activities of Xylometazoline.]
[C08CA12, mepirodipine, Procaine may increase the orthostatic hypotensive activities of Barnidipine.]
[S01EA01, epinephrine, Procaine may increase the hypertensive activities of Epinephrine.]
[L01DB03, epirubicin, The risk or severity of methemoglobinemia can be increased when Epirubicin is combined with Procaine.]
[C09AA15, zofenopril, Procaine may increase the hypotensive activities of Zofenopril.]
[N05CF02, zolpidem, Procaine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[N03AX15, zonisamide, The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Procaine.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Procaine is combined with Insulin glulisine.]
[N05CF01, zopiclone, The risk or severity of adverse effects can be increased when Procaine is combined with Zopiclone.]
[N05AX11, zotepine, The risk or severity of adverse effects can be increased when Procaine is combined with Zotepine.]
[B01AD03, anistreplase, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Anistreplase.]
[L01XA02, carboplatin, The risk or severity of methemoglobinemia can be increased when Carboplatin is combined with Procaine.]
[C02AC02, guanfacine, Procaine may increase the hypotensive activities of Guanfacine.]
[B01AC11, iloprost, Procaine may increase the orthostatic hypotensive activities of Iloprost.]
[C01BG01, moricizine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Moricizine.]
[G02AB03, ergonovine, Procaine may increase the hypertensive activities of Ergometrine.]
[C04AE01, ergoloid mesylates, USP, The risk or severity of adverse effects can be increased when Procaine is combined with Ergoloid mesylate.]
[N02CA02, ergotamine, The metabolism of Ergotamine can be decreased when combined with Procaine.]
[N03AG01, valproic acid, The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Procaine.]
[S01AA17, erythromycin, The risk or severity of methemoglobinemia can be increased when Erythromycin is combined with Procaine.]
[N05CD04, estazolam, The risk or severity of methemoglobinemia can be increased when Estazolam is combined with Procaine.]
[L01XX11, estramustine, The risk or severity of methemoglobinemia can be increased when Estramustine is combined with Procaine.]
[J04AK02, ethambutol, The risk or severity of methemoglobinemia can be increased when Ethambutol is combined with Procaine.]
[R03BA09, fluticasone furoate, The therapeutic efficacy of Procaine can be decreased when used in combination with Fluticasone furoate.]
[R03BA05, fluticasone, The therapeutic efficacy of Procaine can be decreased when used in combination with Fluticasone.]
[C01CA15, gepefrine, Procaine may increase the hypertensive activities of Gepefrine.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Procaine.]
[V03AF05, amifostine, Procaine may increase the orthostatic hypotensive activities of Amifostine.]
[J04AD03, ethionamide, The risk or severity of methemoglobinemia can be increased when Ethionamide is combined with Procaine.]
[L01AG01, ethoglucid, The risk or severity of methemoglobinemia can be increased when Etoglucid is combined with Procaine.]
[N04AA05, profenamine, Profenamine may increase the neuromuscular blocking activities of Procaine.]
[N03AD01, ethosuximide, The risk or severity of methemoglobinemia can be increased when Ethosuximide is combined with Procaine.]
[N03AB01, ethotoin, The risk or severity of methemoglobinemia can be increased when Ethotoin is combined with Procaine.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Meloxicam.]
[S01XA06, ethylmorphine, The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Procaine.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Etidocaine.]
[N01AX07, etomidate, The risk or severity of adverse effects can be increased when Etomidate is combined with Procaine.]
[L01CB01, etoposide, The risk or severity of methemoglobinemia can be increased when Etoposide is combined with Procaine.]
[N05AE03, sertindole, The risk or severity of adverse effects can be increased when Procaine is combined with Sertindole.]
[A02BA04, nizatidine, Nizatidine may increase the neuromuscular blocking activities of Procaine.]
[J01MA08, fleroxacin, The risk or severity of methemoglobinemia can be increased when Fleroxacin is combined with Procaine.]
[R06AX12, terfenadine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Terfenadine.]
[P01AX07, trimetrexate, The risk or severity of methemoglobinemia can be increased when Trimetrexate is combined with Procaine.]
[N06AX12, bupropion, The risk or severity of adverse effects can be increased when Procaine is combined with Bupropion.]
[N06AB08, fluvoxamine, Procaine may increase the serotonergic activities of Fluvoxamine.]
[R01AX06, mupirocin, The risk or severity of methemoglobinemia can be increased when Mupirocin is combined with Procaine.]
[L02AE02, leuprolide, The risk or severity of methemoglobinemia can be increased when Leuprolide is combined with Procaine.]
[B05AA05, dextran, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Dextran.]
[C08CA02, felodipine, Procaine may increase the hypotensive activities of Felodipine.]
[N03AX26, fenfluramine, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Fenfluramine.]
[R03CC04, fenoterol, The risk or severity of adverse effects can be increased when Procaine is combined with Fenoterol.]
[N02AB03, fentanyl, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Fentanyl.]
[R03CC02, albuterol, The risk or severity of adverse effects can be increased when Procaine is combined with Salbutamol.]
[B01AD05, plasmin, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Fibrinolysin.]
[L01BB06, clofarabine, The risk or severity of methemoglobinemia can be increased when Clofarabine is combined with Procaine.]
[L04AA40, cladribine, The risk or severity of methemoglobinemia can be increased when Cladribine is combined with Procaine.]
[N07AX03, cevimeline, The risk or severity of adverse effects can be increased when Procaine is combined with Cevimeline.]
[G04BD02, flavoxate, Procaine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[J01CF05, floxacillin, The risk or severity of methemoglobinemia can be increased when Flucloxacillin is combined with Procaine.]
[H02AA02, fludrocortisone, The therapeutic efficacy of Procaine can be decreased when used in combination with Fludrocortisone.]
[D07XB01, flumethasone, The therapeutic efficacy of Procaine can be decreased when used in combination with Flumethasone.]
[N07CA03, flunarizine, The risk or severity of methemoglobinemia can be increased when Flunarizine is combined with Procaine.]
[N05CD03, flunitrazepam, The risk or severity of adverse effects can be increased when Procaine is combined with Flunitrazepam.]
[D07AC08, fluocinonide, The therapeutic efficacy of Procaine can be decreased when used in combination with Fluocinonide.]
[N06AA14, melitracen, Procaine may increase the serotonergic activities of Melitracen.]
[H02AB03, fluocortolone, The therapeutic efficacy of Procaine can be decreased when used in combination with Fluocortolone.]
[V03AZ01, ethanol, Procaine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[L01BC09, floxuridine, The risk or severity of methemoglobinemia can be increased when Floxuridine is combined with Procaine.]
[S01CB05, fluorometholone, The therapeutic efficacy of Procaine can be decreased when used in combination with Fluorometholone.]
[L01BC02, fluorouracil, The risk or severity of methemoglobinemia can be increased when Fluorouracil is combined with Procaine.]
[N06AB03, fluoxetine, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Fluoxetine.]
[N05AF01, flupenthixol, Procaine may increase the central nervous system depressant (CNS depressant) activities of Flupentixol.]
[N05AB02, fluphenazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Fluphenazine.]
[N05CD01, flurazepam, The risk or severity of adverse effects can be increased when Flurazepam is combined with Procaine.]
[N05AG01, fluspirilene, The risk or severity of adverse effects can be increased when Procaine is combined with Fluspirilene.]
[L02BB01, flutamide, The risk or severity of methemoglobinemia can be increased when Flutamide is combined with Procaine.]
[S02AA17, fosfomycin, The risk or severity of methemoglobinemia can be increased when Fosfomycin is combined with Procaine.]
[S01AA07, framycetin, The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Procaine.]
[L01BC03, tegafur, The risk or severity of methemoglobinemia can be increased when Tegafur is combined with Procaine.]
[M03AA01, alcuronium, The risk or severity of adverse effects can be increased when Procaine is combined with Alcuronium.]
[G01AX06, furazolidone, The risk or severity of adverse effects can be increased when Furazolidone is combined with Procaine.]
[C03CA01, furosemide, Procaine may increase the hypotensive activities of Furosemide.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Procaine is combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Procaine is combined with Amisulpride.]
[N06DA04, galantamine, Galantamine may increase the neuromuscular blocking activities of Procaine.]
[M03AC02, gallamine, The risk or severity of adverse effects can be increased when Procaine is combined with Gallamine.]
[N03AA04, barbexaclone, The risk or severity of methemoglobinemia can be increased when Barbexaclone is combined with Procaine.]
[N06AX08, bifemelane, The risk or severity of adverse effects can be increased when Procaine is combined with Bifemelane.]
[J01XA03, telavancin, The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Procaine.]
[L02BX02, degarelix, The risk or severity of methemoglobinemia can be increased when Degarelix is combined with Procaine.]
[L01EA02, dasatinib, The risk or severity of methemoglobinemia can be increased when Dasatinib is combined with Procaine.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be decreased when combined with Procaine.]
[A10BJ02, liraglutide, Procaine may increase the hypoglycemic activities of Liraglutide.]
[N03AD03, methsuximide, The risk or severity of methemoglobinemia can be increased when Methsuximide is combined with Procaine.]
[N01AH02, alfentanil, The risk or severity of adverse effects can be increased when Alfentanil is combined with Procaine.]
[L01EH01, lapatinib, The risk or severity of methemoglobinemia can be increased when Lapatinib is combined with Procaine.]
[A10BB01, glyburide, Procaine may increase the hypoglycemic activities of Glyburide.]
[A10BB09, gliclazide, Procaine may increase the hypoglycemic activities of Gliclazide.]
[A10BB07, glipizide, Procaine may increase the hypoglycemic activities of Glipizide.]
[N05CM18, dexmedetomidine, Procaine may increase the orthostatic hypotensive activities of Dexmedetomidine.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Procaine is combined with Glutethimide.]
[A06AX01, glycerin, The therapeutic efficacy of Glycerin can be decreased when used in combination with Procaine.]
[C05AE01, nitroglycerin, Procaine may increase the hypotensive activities of Nitroglycerin.]
[C02CA04, doxazosin, Procaine may increase the hypotensive activities of Doxazosin.]
[L01EX02, sorafenib, The risk or severity of methemoglobinemia can be increased when Sorafenib is combined with Procaine.]
[C07AB09, esmolol, Procaine may increase the bradycardic activities of Esmolol.]
[B01AA12, fluindione, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Fluindione.]
[R02AB30, gramicidin, The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Procaine.]
[C09AA09, fosinopril, Procaine may increase the hypotensive activities of Fosinopril.]
[S01EX01, guanethidine, Procaine may increase the hypotensive activities of Guanethidine.]
[L02AE03, goserelin, The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Procaine.]
[P01BX01, halofantrine, The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Procaine.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Procaine.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Halothane is combined with Procaine.]
[N05AH04, quetiapine, Procaine may increase the orthostatic hypotensive activities of Quetiapine.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Procaine is combined with Insulin aspart.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Procaine is combined with Iprazochrome.]
[L01CE02, irinotecan, The risk or severity of methemoglobinemia can be increased when Irinotecan is combined with Procaine.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Procaine is combined with Allobarbital.]
[C09CA01, losartan, Procaine may increase the hypotensive activities of Losartan.]
[S01XA14, heparin, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Heparin.]
[B05CB03, magnesium citrate, The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Procaine.]
[A12CD02, sodium monofluorophosphate, The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Procaine.]
[L01XX03, altretamine, Altretamine may increase the orthostatic hypotensive activities of Procaine.]
[N05CA16, hexobarbital, The risk or severity of methemoglobinemia can be increased when Hexobarbital is combined with Procaine.]
[R03CC05, hexoprenaline, The risk or severity of adverse effects can be increased when Procaine is combined with Hexoprenaline.]
[C08CA10, nilvadipine, Procaine may increase the hypotensive activities of Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Nimesulide.]
[C09AA04, perindopril, Procaine may increase the hypotensive activities of Perindopril.]
[C02DB02, hydralazine, Procaine may increase the hypotensive activities of Hydralazine.]
[C03AA03, hydrochlorothiazide, Procaine may increase the hypotensive activities of Hydrochlorothiazide.]
[R05DA03, hydrocodone, Procaine may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[S02BA01, hydrocortisone, The therapeutic efficacy of Procaine can be decreased when used in combination with Hydrocortisone.]
[D07AB02, hydrocortisone butyrate, The therapeutic efficacy of Procaine can be decreased when used in combination with Hydrocortisone butyrate.]
[C03AA02, hydroflumethiazide, Procaine may increase the hypotensive activities of Hydroflumethiazide.]
[G04BD06, propiverine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Propiverine.]
[P01BA02, hydroxychloroquine, The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Procaine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Procaine is combined with Prothipendyl.]
[L01XX05, hydroxyurea, The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Procaine.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Procaine.]
[J04AB04, rifabutin, The risk or severity of methemoglobinemia can be increased when Rifabutin is combined with Procaine.]
[C02AC06, rilmenidine, Procaine may increase the hypotensive activities of Rilmenidine.]
[B05CB02, sodium citrate, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Sodium citrate.]
[L01DB06, idarubicin, The risk or severity of methemoglobinemia can be increased when Idarubicin is combined with Procaine.]
[A06AD21, sodium tartrate, The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Procaine.]
[L01AA06, ifosfamide, The risk or severity of methemoglobinemia can be increased when Ifosfamide is combined with Procaine.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Sufentanil is combined with Procaine.]
[N06AA02, imipramine, Procaine may increase the serotonergic activities of Imipramine.]
[L01CD01, paclitaxel, The risk or severity of methemoglobinemia can be increased when Paclitaxel is combined with Procaine.]
[L01CD03, paclitaxel poliglumex, The risk or severity of methemoglobinemia can be increased when Paclitaxel poliglumex is combined with Procaine.]
[J01XA02, teicoplanin, The risk or severity of methemoglobinemia can be increased when Teicoplanin is combined with Procaine.]
[R01AD07, tixocortol, The therapeutic efficacy of Procaine can be decreased when used in combination with Tixocortol.]
[M03BX02, tizanidine, The risk or severity of methemoglobinemia can be increased when Tizanidine is combined with Procaine.]
[L01CE01, topotecan, The risk or severity of methemoglobinemia can be increased when Topotecan is combined with Procaine.]
[C03BA11, indapamide, Procaine may increase the hypotensive activities of Indapamide.]
[C02CA02, indoramin, Procaine may increase the hypotensive activities of Indoramin.]
[L03AB04, interferon alfa-2a, The risk or severity of methemoglobinemia can be increased when Interferon alfa-2a is combined with Procaine.]
[L03AB05, interferon alfa-2b, The risk or severity of methemoglobinemia can be increased when Interferon alfa-2b is combined with Procaine.]
[N06AX17, milnacipran, Procaine may increase the serotonergic activities of Milnacipran.]
[A03AA30, piperidolate, Procaine may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[S01XA28, varenicline, The risk or severity of adverse effects can be increased when Procaine is combined with Varenicline.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Articaine.]
[A10BH01, sitagliptin, Procaine may increase the hypoglycemic activities of Sitagliptin.]
[N05BA12, alprazolam, The risk or severity of adverse effects can be increased when Alprazolam is combined with Procaine.]
[N05CH02, ramelteon, The risk or severity of adverse effects can be increased when Procaine is combined with Ramelteon.]
[R06AE01, buclizine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[A10BH02, vildagliptin, Procaine may increase the hypoglycemic activities of Vildagliptin.]
[L01XX35, anagrelide, The risk or severity of methemoglobinemia can be increased when Anagrelide is combined with Procaine.]
[C07AA01, alprenolol, Procaine may increase the bradycardic activities of Alprenolol.]
[C03BA02, quinethazone, The serum concentration of Quinethazone can be increased when it is combined with Procaine.]
[N06AA13, iprindole, Procaine may increase the serotonergic activities of Iprindole.]
[N06AF05, iproniazid, The risk or severity of adverse effects can be increased when Procaine is combined with Iproniazid.]
[N05AA07, chlorproethazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Chlorproethazine.]
[N06AF01, isocarboxazid, The risk or severity of adverse effects can be increased when Procaine is combined with Isocarboxazid.]
[P01AX06, atovaquone, The risk or severity of methemoglobinemia can be increased when Atovaquone is combined with Procaine.]
[R03CC06, isoetharine, The risk or severity of adverse effects can be increased when Procaine is combined with Isoetharine.]
[C09AA16, imidapril, Procaine may increase the hypotensive activities of Imidapril.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Isoflurane is combined with Procaine.]
[S01EB07, isoflurophate, Isoflurophate may increase the neuromuscular blocking activities of Procaine.]
[N04BX02, entacapone, The risk or severity of adverse effects can be increased when Entacapone is combined with Procaine.]
[J04AC01, isoniazid, The risk or severity of methemoglobinemia can be increased when Isoniazid is combined with Procaine.]
[R03CB01, isoproterenol, Isoprenaline may increase the neuromuscular blocking activities of Procaine.]
[A10BJ01, exenatide, Procaine may increase the hypoglycemic activities of Exenatide.]
[C01DA14, isosorbide mononitrate, Procaine may increase the orthostatic hypotensive activities of Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, Procaine may increase the orthostatic hypotensive activities of Isosorbide dinitrate.]
[C04AA01, isoxsuprine, Procaine may increase the orthostatic hypotensive activities of Isoxsuprine.]
[B01AE06, bivalirudin, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Bivalirudin.]
[J01FA07, josamycin, The risk or severity of methemoglobinemia can be increased when Josamycin is combined with Procaine.]
[N06AX18, reboxetine, The risk or severity of adverse effects can be increased when Reboxetine is combined with Procaine.]
[S01AA24, kanamycin, The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Procaine.]
[N01AX03, ketamine, Ketamine may increase the neuromuscular blocking activities of Procaine.]
[C02KD01, ketanserin, Procaine may increase the hypotensive activities of Ketanserin.]
[B01AC22, prasugrel, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Prasugrel.]
[N05AH03, olanzapine, Procaine may increase the orthostatic hypotensive activities of Olanzapine.]
[C01CA22, arbutamine, The risk or severity of adverse effects can be increased when Procaine is combined with Arbutamine.]
[N04BC09, rotigotine, Procaine may increase the sedative activities of Rotigotine.]
[J01MB02, nalidixic acid, The risk or severity of methemoglobinemia can be increased when Nalidixic acid is combined with Procaine.]
[C07AG01, labetalol, Procaine may increase the bradycardic activities of Labetalol.]
[N04BB01, amantadine, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Amantadine.]
[C02AA05, deserpidine, Procaine may increase the hypotensive activities of Deserpidine.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Procaine.]
[N07AA30, ambenonium, Ambenonium may increase the neuromuscular blocking activities of Procaine.]
[A06AX03, lubiprostone, The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Procaine.]
[N03AX18, lacosamide, The risk or severity of methemoglobinemia can be increased when Lacosamide is combined with Procaine.]
[C03CC01, ethacrynic acid, Procaine may increase the orthostatic hypotensive activities of Etacrynic acid.]
[J01CA11, amdinocillin, The risk or severity of methemoglobinemia can be increased when Amdinocillin is combined with Procaine.]
[J01CA08, amdinocillin pivoxil, The risk or severity of methemoglobinemia can be increased when Pivmecillinam is combined with Procaine.]
[L01DC03, mitomycin, The risk or severity of methemoglobinemia can be increased when Mitomycin is combined with Procaine.]
[N04BA01, levodopa, Procaine may increase the orthostatic hypotensive activities of Levodopa.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Lidocaine is combined with Procaine.]
[J01FF02, lincomycin, The risk or severity of methemoglobinemia can be increased when Lincomycin is combined with Procaine.]
[S01AA21, amikacin, The risk or severity of methemoglobinemia can be increased when Amikacin is combined with Procaine.]
[C03DB01, amiloride, Procaine may increase the orthostatic hypotensive activities of Amiloride.]
[N02CA07, lisuride, The metabolism of Lisuride can be decreased when combined with Procaine.]
[N06AA07, lofepramine, Procaine may increase the serotonergic activities of Lofepramine.]
[L01AD02, lomustine, The risk or severity of methemoglobinemia can be increased when Lomustine is combined with Procaine.]
[N05BA06, lorazepam, The risk or severity of methemoglobinemia can be increased when Lorazepam is combined with Procaine.]
[N05AH01, loxapine, The risk or severity of adverse effects can be increased when Loxapine is combined with Procaine.]
[J01AA04, lymecycline, The risk or severity of methemoglobinemia can be increased when Lymecycline is combined with Procaine.]
[L01EG01, temsirolimus, The risk or severity of methemoglobinemia can be increased when Temsirolimus is combined with Procaine.]
[G04BX01, magnesium hydroxide, The therapeutic efficacy of Magnesium hydroxide can be decreased when used in combination with Procaine.]
[A12CC10, magnesium oxide, The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Procaine.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Procaine can be increased when used in combination with Magnesium sulfate.]
[L01BA05, pralatrexate, The risk or severity of methemoglobinemia can be increased when Pralatrexate is combined with Procaine.]
[L01EA03, nilotinib, The risk or severity of methemoglobinemia can be increased when Nilotinib is combined with Procaine.]
[V04CX04, mannitol, Procaine may increase the orthostatic hypotensive activities of Mannitol.]
[N06AA21, maprotiline, The risk or severity of adverse effects can be increased when Procaine is combined with Maprotiline.]
[A08AA05, mazindol, The risk or severity of adverse effects can be increased when Mazindol is combined with Procaine.]
[C02BB01, mecamylamine, Procaine may increase the hypotensive activities of Mecamylamine.]
[L01AA05, mechlorethamine, The risk or severity of methemoglobinemia can be increased when Mechlorethamine is combined with Procaine.]
[R06AE05, meclizine, The risk or severity of adverse effects can be increased when Procaine is combined with Meclizine.]
[N05BA03, medazepam, The risk or severity of methemoglobinemia can be increased when Medazepam is combined with Procaine.]
[A06AB07, cascara sagrada, The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Procaine.]
[P01BC02, mefloquine, The risk or severity of methemoglobinemia can be increased when Mefloquine is combined with Procaine.]
[J01FG01, pristinamycin, The risk or severity of methemoglobinemia can be increased when Pristinamycin is combined with Procaine.]
[B01AB06, nadroparin, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Nadroparin.]
[B01AB05, enoxaparin, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Enoxaparin.]
[B01AB04, dalteparin, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Dalteparin.]
[N05CH01, melatonin, The risk or severity of adverse effects can be increased when Procaine is combined with Melatonin.]
[L01AA03, melphalan, The risk or severity of methemoglobinemia can be increased when Melphalan is combined with Procaine.]
[N06DX01, memantine, The risk or severity of adverse effects can be increased when Procaine is combined with Memantine.]
[N02AB02, meperidine, The risk or severity of serotonin syndrome and opioid toxicity can be increased when Procaine is combined with Meperidine.]
[C01CA11, mephentermine, Procaine may increase the hypertensive activities of Mephentermine.]
[N03AB04, mephenytoin, The risk or severity of methemoglobinemia can be increased when Mephenytoin is combined with Procaine.]
[N03AA01, mephobarbital, The risk or severity of methemoglobinemia can be increased when Methylphenobarbital is combined with Procaine.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Mepivacaine.]
[N05BC01, meprobamate, The risk or severity of adverse effects can be increased when Meprobamate is combined with Procaine.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Meptazinol is combined with Procaine.]
[L02BG01, aminoglutethimide, The risk or severity of methemoglobinemia can be increased when Aminoglutethimide is combined with Procaine.]
[N05AC03, mesoridazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Mesoridazine.]
[N05AX13, paliperidone, The risk or severity of adverse effects can be increased when Procaine is combined with Paliperidone.]
[C01CA09, metaraminol, Procaine may increase the hypertensive activities of Metaraminol.]
[A10BA02, metformin, Procaine may increase the hypoglycemic activities of Metformin.]
[A04AA04, dolasetron, The risk or severity of adverse effects can be increased when Procaine is combined with Dolasetron.]
[H01CB03, lanreotide, The risk or severity of methemoglobinemia can be increased when Lanreotide is combined with Procaine.]
[J01AA05, methacycline, The risk or severity of methemoglobinemia can be increased when Metacycline is combined with Procaine.]
[N07BC02, methadone, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Methadone.]
[N06BA03, methamphetamine, Procaine may increase the hypertensive activities of Metamfetamine.]
[A03AB07, methantheline, Procaine may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Procaine is combined with Methapyrilene.]
[N05CM01, methaqualone, The risk or severity of adverse effects can be increased when Procaine is combined with Methaqualone.]
[N03AA30, metharbital, The risk or severity of methemoglobinemia can be increased when Metharbital is combined with Procaine.]
[S01EC05, methazolamide, Procaine may increase the orthostatic hypotensive activities of Methazolamide.]
[L01XD04, aminolevulinic acid, The risk or severity of methemoglobinemia can be increased when Aminolevulinic acid is combined with Procaine.]
[J01XX05, methenamine, The risk or severity of methemoglobinemia can be increased when Methenamine is combined with Procaine.]
[G02CB05, metergoline, The risk or severity of adverse effects can be increased when Procaine is combined with Metergoline.]
[L01BA04, pemetrexed, The risk or severity of methemoglobinemia can be increased when Pemetrexed is combined with Procaine.]
[M03BA03, methocarbamol, The risk or severity of adverse effects can be increased when Methocarbamol is combined with Procaine.]
[N05CA15, methohexital, The risk or severity of methemoglobinemia can be increased when Methohexital is combined with Procaine.]
[N02BG08, ziconotide, The risk or severity of adverse effects can be increased when Procaine is combined with Ziconotide.]
[L04AX03, methotrexate, The risk or severity of methemoglobinemia can be increased when Methotrexate is combined with Procaine.]
[N05AA02, methotrimeprazine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.]
[C01CA10, methoxamine, Procaine may increase the hypertensive activities of Methoxamine.]
[N02BG09, methoxyflurane, The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Procaine.]
[C03AA08, methyclothiazide, Procaine may increase the orthostatic hypotensive activities of Methyclothiazide.]
[A06AC06, methylcellulose, The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Procaine.]
[C02AB01, methyldopa, Procaine may decrease the hypotensive activities of Methyldopa.]
[V04CG05, methylene blue, Procaine may increase the serotonergic activities of Methylene blue.]
[N06BA04, methylphenidate, Procaine may increase the hypertensive activities of Methylphenidate.]
[H02AB04, methylprednisolone, The risk or severity of methemoglobinemia can be increased when Methylprednisolone is combined with Procaine.]
[D07AC14, methylprednisolone aceponate, The therapeutic efficacy of Procaine can be decreased when used in combination with Methylprednisolone aceponate.]
[N03AF03, rufinamide, The risk or severity of adverse effects can be increased when Rufinamide is combined with Procaine.]
[G03EK01, methyltestosterone, The risk or severity of methemoglobinemia can be increased when Methyltestosterone is combined with Procaine.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Procaine is combined with Methyprylon.]
[N02CA04, methysergide, The risk or severity of adverse effects can be increased when Methysergide is combined with Procaine.]
[A03FA01, metoclopramide, The risk or severity of adverse effects can be increased when Procaine is combined with Metoclopramide.]
[C03BA08, metolazone, Procaine may increase the hypotensive activities of Metolazone.]
[C07AB02, metoprolol, Procaine may increase the bradycardic activities of Metoprolol.]
[P01AB01, metronidazole, The risk or severity of methemoglobinemia can be increased when Metronidazole is combined with Procaine.]
[J01CA10, mezlocillin, The risk or severity of methemoglobinemia can be increased when Mezlocillin is combined with Procaine.]
[N06AX03, mianserin, The risk or severity of adverse effects can be increased when Procaine is combined with Mianserin.]
[B01AB07, parnaparin, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Parnaparin.]
[N05CD08, midazolam, The risk or severity of adverse effects can be increased when Midazolam is combined with Procaine.]
[C01CA17, midodrine, Procaine may increase the hypertensive activities of Midodrine.]
[G03XB01, mifepristone, Procaine may increase the hypoglycemic activities of Mifepristone.]
[B01AB10, tinzaparin, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Tinzaparin.]
[A06AA01, mineral oil, The therapeutic efficacy of Mineral oil can be decreased when used in combination with Procaine.]
[C09CA03, valsartan, Procaine may increase the hypotensive activities of Valsartan.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Procaine.]
[D11AX01, minoxidil, Procaine may increase the hypotensive activities of Minoxidil.]
[J01FA11, miocamycin, The risk or severity of methemoglobinemia can be increased when Miocamycin is combined with Procaine.]
[L01DC02, plicamycin, The risk or severity of methemoglobinemia can be increased when Plicamycin is combined with Procaine.]
[L01AX01, mitobronitol, The risk or severity of methemoglobinemia can be increased when Mitobronitol is combined with Procaine.]
[L01XX23, mitotane, The risk or severity of methemoglobinemia can be increased when Mitotane is combined with Procaine.]
[L01DB07, mitoxantrone, The risk or severity of methemoglobinemia can be increased when Mitoxantrone is combined with Procaine.]
[N06BA12, lisdexamfetamine, Procaine may increase the hypertensive activities of Lisdexamfetamine.]
[L03AA03, molgramostim, The risk or severity of methemoglobinemia can be increased when Molgramostim is combined with Procaine.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Procaine is combined with Molindone.]
[L03AC01, aldesleukin, The risk or severity of methemoglobinemia can be increased when Aldesleukin is combined with Procaine.]
[C01BD01, amiodarone, Procaine may increase the orthostatic hypotensive activities of Amiodarone.]
[N06AA09, amitriptyline, Procaine may increase the serotonergic activities of Amitriptyline.]
[N02AA01, morphine, Procaine may increase the analgesic activities of Morphine.]
[A04AA05, palonosetron, The risk or severity of adverse effects can be increased when Palonosetron is combined with Procaine.]
[J01DD06, moxalactam, The risk or severity of methemoglobinemia can be increased when Latamoxef is combined with Procaine.]
[L04AA52, ofatumumab, The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Procaine.]
[L01EX03, pazopanib, The risk or severity of methemoglobinemia can be increased when Pazopanib is combined with Procaine.]
[L04AA06, mycophenolic acid, The risk or severity of methemoglobinemia can be increased when Mycophenolic acid is combined with Procaine.]
[M03AC03, vecuronium, The risk or severity of adverse effects can be increased when Procaine is combined with Vecuronium.]
[N05CA02, amobarbital, The risk or severity of methemoglobinemia can be increased when Amobarbital is combined with Procaine.]
[P01BA06, amodiaquine, The risk or severity of methemoglobinemia can be increased when Amodiaquine is combined with Procaine.]
[R03BB01, ipratropium bromide, Procaine may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
[N06AA17, amoxapine, Procaine may increase the serotonergic activities of Amoxapine.]
[N03AB05, fosphenytoin, The risk or severity of methemoglobinemia can be increased when Fosphenytoin is combined with Procaine.]
[C07AA12, nadolol, Procaine may increase the bradycardic activities of Nadolol.]
[J01CA04, amoxicillin, The risk or severity of methemoglobinemia can be increased when Amoxicillin is combined with Procaine.]
[N04BC04, ropinirole, Procaine may increase the sedative activities of Ropinirole.]
[J01CF06, nafcillin, The risk or severity of methemoglobinemia can be increased when Nafcillin is combined with Procaine.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Procaine is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The risk or severity of adverse effects can be increased when Nalbuphine is combined with Procaine.]
[N07BB04, naltrexone, The risk or severity of adverse effects can be increased when Procaine is combined with Naltrexone.]
[S01GA01, naphazoline, Procaine may increase the hypertensive activities of Naphazoline.]
[N06BA01, amphetamine, Procaine may increase the hypertensive activities of Amphetamine.]
[A10BG01, troglitazone, Procaine may increase the hypoglycemic activities of Troglitazone.]
[N06AX21, duloxetine, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Duloxetine.]
[S01AA10, natamycin, The risk or severity of methemoglobinemia can be increased when Natamycin is combined with Procaine.]
[N04BX01, tolcapone, Procaine may increase the orthostatic hypotensive activities of Tolcapone.]
[L01CD02, docetaxel, The risk or severity of methemoglobinemia can be increased when Docetaxel is combined with Procaine.]
[L02BG04, letrozole, The risk or severity of methemoglobinemia can be increased when Letrozole is combined with Procaine.]
[S03AA01, neomycin, The risk or severity of methemoglobinemia can be increased when Neomycin is combined with Procaine.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Remifentanil is combined with Procaine.]
[A10BX02, repaglinide, Procaine may increase the hypoglycemic activities of Repaglinide.]
[C01CX08, levosimendan, Procaine may increase the orthostatic hypotensive activities of Levosimendan.]
[B01AC17, tirofiban, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Tirofiban.]
[S01EB06, neostigmine, Neostigmine may increase the neuromuscular blocking activities of Procaine.]
[N05AX14, iloperidone, The risk or severity of adverse effects can be increased when Procaine is combined with Iloperidone.]
[J02AA01, amphotericin B, The risk or severity of methemoglobinemia can be increased when Amphotericin B is combined with Procaine.]
[S01AA19, ampicillin, The risk or severity of methemoglobinemia can be increased when Ampicillin is combined with Procaine.]
[S01AA23, netilmicin, The risk or severity of methemoglobinemia can be increased when Netilmicin is combined with Procaine.]
[N06AX23, desvenlafaxine, Procaine may increase the serotonergic activities of Desvenlafaxine.]
[C09CA07, telmisartan, Procaine may increase the hypotensive activities of Telmisartan.]
[L01XX01, amsacrine, The risk or severity of methemoglobinemia can be increased when Amsacrine is combined with Procaine.]
[N06AF02, nialamide, The risk or severity of adverse effects can be increased when Procaine is combined with Nialamide.]
[C08CA04, nicardipine, Procaine may increase the hypotensive activities of Nicardipine.]
[N07BA01, nicotine, The risk or severity of adverse effects can be increased when Procaine is combined with Nicotine.]
[C08CA05, nifedipine, Procaine may increase the orthostatic hypotensive activities of Nifedipine.]
[V03AB22, amyl nitrite, Procaine may increase the orthostatic hypotensive activities of Amyl Nitrite.]
[C08CA06, nimodipine, Procaine may increase the hypotensive activities of Nimodipine.]
[C08CA07, nisoldipine, Procaine may increase the hypotensive activities of Nisoldipine.]
[N05CD02, nitrazepam, The risk or severity of methemoglobinemia can be increased when Nitrazepam is combined with Procaine.]
[C08CA08, nitrendipine, Procaine may increase the hypotensive activities of Nitrendipine.]
[R07AX01, nitric oxide, Procaine may increase the orthostatic hypotensive activities of Nitric Oxide.]
[J01XE01, nitrofurantoin, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Procaine.]
[N05CF03, zaleplon, The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Procaine.]
[N04BC05, pramipexole, Procaine may increase the sedative activities of Pramipexole.]
[C02DD01, nitroprusside, Procaine may increase the hypotensive activities of Nitroprusside.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Procaine.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Procaine is combined with Nomifensine.]
[C01CA03, norepinephrine, Procaine may increase the hypertensive activities of Norepinephrine.]
[S01AE02, norfloxacin, The risk or severity of methemoglobinemia can be increased when Norfloxacin is combined with Procaine.]
[C02KX01, bosentan, Procaine may increase the hypotensive activities of Bosentan.]
[N06AA10, nortriptyline, Procaine may increase the serotonergic activities of Nortriptyline.]
[B01AC16, eptifibatide, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Eptifibatide.]
[B01AB08, reviparin, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Reviparin.]
[H01CB02, octreotide, The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Procaine.]
[S02AA16, ofloxacin, The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Procaine.]
[J01FA05, oleandomycin, The risk or severity of methemoglobinemia can be increased when Oleandomycin is combined with Procaine.]
[N06AA05, opipramol, Procaine may increase the serotonergic activities of Opipramol.]
[N02AA02, opium, The risk or severity of adverse effects can be increased when Opium is combined with Procaine.]
[R03CB03, metaproterenol, The risk or severity of adverse effects can be increased when Procaine is combined with Orciprenaline.]
[B01AD07, reteplase, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Reteplase.]
[B01AD09, ancrod, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Ancrod.]
[G04CA02, tamsulosin, Procaine may increase the orthostatic hypotensive activities of Tamsulosin.]
[J01CF04, oxacillin, The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Procaine.]
[N05BA04, oxazepam, The risk or severity of adverse effects can be increased when Procaine is combined with Oxazepam.]
[J01MB05, oxolinic acid, The risk or severity of methemoglobinemia can be increased when Oxolinic acid is combined with Procaine.]
[C07AA02, oxprenolol, Procaine may increase the bradycardic activities of Oxprenolol.]
[N02AA05, oxycodone, Procaine may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Oxycodone.]
[S01GA04, oxymetazoline, The serum concentration of Oxymetazoline can be increased when it is combined with Procaine.]
[N02AA11, oxymorphone, The risk or severity of adverse effects can be increased when Oxymorphone is combined with Procaine.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Procaine is combined with Oxypertine.]
[A03AB03, oxyphenonium, Procaine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[S01AA04, oxytetracycline, The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Procaine.]
[J04AA01, aminosalicylic acid, The risk or severity of methemoglobinemia can be increased when Aminosalicylic acid is combined with Procaine.]
[N05AH05, asenapine, The risk or severity of adverse effects can be increased when Procaine is combined with Asenapine.]
[B01AB09, danaparoid, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Danaparoid.]
[N02AX06, tapentadol, The risk or severity of adverse effects can be increased when Tapentadol is combined with Procaine.]
[M03AC01, pancuronium, Pancuronium may increase the neuromuscular blocking activities of Procaine.]
[J04AB30, capreomycin, The risk or severity of methemoglobinemia can be increased when Capreomycin is combined with Procaine.]
[G04BE02, papaverine, Procaine may increase the orthostatic hypotensive activities of Papaverine.]
[N05CC05, paraldehyde, Procaine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[H02AB05, paramethasone, The therapeutic efficacy of Procaine can be decreased when used in combination with Paramethasone.]
[C02KC01, pargyline, The risk or severity of adverse effects can be increased when Procaine is combined with Pargyline.]
[A07AA06, paromomycin, The risk or severity of methemoglobinemia can be increased when Paromomycin is combined with Procaine.]
[J01MA03, pefloxacin, The risk or severity of methemoglobinemia can be increased when Pefloxacin is combined with Procaine.]
[G04BD11, fesoterodine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.]
[C07AA23, penbutolol, Procaine may increase the bradycardic activities of Penbutolol.]
[N05AG03, penfluridol, The risk or severity of adverse effects can be increased when Procaine is combined with Penfluridol.]
[S01AA14, penicillin G, The risk or severity of methemoglobinemia can be increased when Benzylpenicillin is combined with Procaine.]
[J01CE09, penicillin G procaine, The risk or severity of methemoglobinemia can be increased when Procaine benzylpenicillin is combined with Procaine.]
[J01CE02, penicillin V, The risk or severity of methemoglobinemia can be increased when Phenoxymethylpenicillin is combined with Procaine.]
[N02AD01, pentazocine, The risk or severity of adverse effects can be increased when Pentazocine is combined with Procaine.]
[N05CA01, pentobarbital, The risk or severity of methemoglobinemia can be increased when Pentobarbital is combined with Procaine.]
[L01XX08, pentostatin, The risk or severity of methemoglobinemia can be increased when Pentostatin is combined with Procaine.]
[C04AD03, pentoxifylline, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Pentoxifylline.]
[N05AB10, perazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Perazine.]
[N04BC02, pergolide, Procaine may increase the hypertensive activities of Pergolide.]
[L01FX01, edrecolomab, The risk or severity of methemoglobinemia can be increased when Edrecolomab is combined with Procaine.]
[N05AB03, perphenazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Perphenazine.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Phenazocine is combined with Procaine.]
[G04BX06, phenazopyridine, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Phenazopyridine.]
[N06AF03, phenelzine, The risk or severity of adverse effects can be increased when Procaine is combined with Phenelzine.]
[A10BA01, phenformin, Procaine may increase the hypoglycemic activities of Phenformin.]
[B01AA02, phenindione, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Phenindione.]
[N03AA02, phenobarbital, The risk or severity of methemoglobinemia can be increased when Phenobarbital is combined with Procaine.]
[A06AB01, oxyphenisatin, The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Procaine.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Phenoperidine is combined with Procaine.]
[C04AX02, phenoxybenzamine, Procaine may increase the hypotensive activities of Phenoxybenzamine.]
[B01AA04, phenprocoumon, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Phenprocoumon.]
[A08AA01, phentermine, Procaine may increase the hypertensive activities of Phentermine.]
[V03AB36, phentolamine, Procaine may increase the hypotensive activities of Phentolamine.]
[S01GA05, phenylephrine, Procaine may increase the hypertensive activities of Phenylephrine.]
[R01BA01, phenylpropanolamine, The risk or severity of adverse effects can be increased when Procaine is combined with Phenylpropanolamine.]
[N03AB02, phenytoin, The risk or severity of methemoglobinemia can be increased when Phenytoin is combined with Procaine.]
[L01XF02, alitretinoin, The risk or severity of methemoglobinemia can be increased when Alitretinoin is combined with Procaine.]
[S01AE08, besifloxacin, The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Procaine.]
[S01AE05, levofloxacin, The risk or severity of methemoglobinemia can be increased when Levofloxacin is combined with Procaine.]
[V03AB19, physostigmine, Physostigmine may increase the neuromuscular blocking activities of Procaine.]
[L02BB03, bicalutamide, The risk or severity of methemoglobinemia can be increased when Bicalutamide is combined with Procaine.]
[C08CX01, mibefradil, Procaine may increase the hypotensive activities of Mibefradil.]
[S01EB01, pilocarpine, The risk or severity of adverse effects can be increased when Procaine is combined with Pilocarpine.]
[N05AG02, pimozide, The risk or severity of adverse effects can be increased when Procaine is combined with Pimozide.]
[C07AA03, pindolol, Procaine may increase the bradycardic activities of Pindolol.]
[J01CA12, piperacillin, The risk or severity of methemoglobinemia can be increased when Piperacillin is combined with Procaine.]
[L01AX02, pipobroman, The risk or severity of methemoglobinemia can be increased when Pipobroman is combined with Procaine.]
[N05AC04, pipothiazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Pipotiazine.]
[C09CA02, eprosartan, Procaine may increase the hypotensive activities of Eprosartan.]
[A02BX03, pirenzepine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Piritramide is combined with Procaine.]
[J01DD16, cefditoren, The risk or severity of methemoglobinemia can be increased when Cefditoren is combined with Procaine.]
[J01MA11, grepafloxacin, The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Procaine.]
[J01CA02, pivampicillin, The risk or severity of methemoglobinemia can be increased when Pivampicillin is combined with Procaine.]
[N02CX01, pizotyline, Procaine may increase the anticholinergic activities of Pizotifen.]
[C09CA04, irbesartan, Procaine may increase the hypotensive activities of Irbesartan.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Procaine is combined with Proxibarbal.]
[B01AC13, abciximab, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Abciximab.]
[S01XA13, alteplase, The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Alteplase.]
[A10BG02, rosiglitazone, Procaine may increase the hypoglycemic activities of Rosiglitazone.]
[L02BG03, anastrozole, The risk or severity of methemoglobinemia can be increased when Anastrozole is combined with Procaine.]
[A06AD15, polyethylene glycols, The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Procaine.]
[A03AE01, alosetron, The risk or severity of adverse effects can be increased when Procaine is combined with Alosetron.]
[S03AA03, polymyxin B, The risk or severity of methemoglobinemia can be increased when Polymyxin B is combined with Procaine.]
[C03AA05, polythiazide, Procaine may increase the hypotensive activities of Polythiazide.]
[A10BH03, saxagliptin, Procaine may increase the hypoglycemic activities of Saxagliptin.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Procaine is combined with Insulin lispro.]
[C07AB01, practolol, Procaine may increase the bradycardic activities of Practolol.]
[N05BA11, prazepam, The risk or severity of adverse effects can be increased when Procaine is combined with Prazepam.]
[C02CA01, prazosin, Procaine may increase the hypotensive activities of Prazosin.]
[L01AA08, prednimustine, The risk or severity of methemoglobinemia can be increased when Prednimustine is combined with Procaine.]
[S03BA02, prednisolone, The risk or severity of methemoglobinemia can be increased when Prednisolone is combined with Procaine.]
[H02AB07, prednisone, The risk or severity of methemoglobinemia can be increased when Prednisone is combined with Procaine.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Procaine is combined with Prilocaine.]
[P01BA03, primaquine, The risk or severity of methemoglobinemia can be increased when Primaquine is combined with Procaine.]
[N03AA03, primidone, The risk or severity of methemoglobinemia can be increased when Primidone is combined with Procaine.]
[C01BA02, procainamide, Procainamide may increase the neuromuscular blocking activities of Procaine.]
[N07XX04, sodium oxybate, The risk or severity of adverse effects can be increased when Procaine is combined with Sodium oxybate.]
[L01XB01, procarbazine, The risk or severity of methemoglobinemia can be increased when Procarbazine is combined with Procaine.]
[N05AB04, prochlorperazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Prochlorperazine.]
[N04AA04, procyclidine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[N05AA03, promazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Promazine.]
[R06AD02, promethazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Promethazine.]
[C01BC03, propafenone, Procaine may increase the bradycardic activities of Propafenone.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Procaine is combined with Propanidid.]
[A03AB05, propantheline, Procaine may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, The risk or severity of extrapyramidal symptoms can be increased when Procaine is combined with Periciazine.]
[N05CM06, propiomazine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.]
[L01XH02, romidepsin, The risk or severity of methemoglobinemia can be increased when Romidepsin is combined with Procaine.]
[N01AX10, propofol, Procaine may increase the orthostatic hypotensive activities of Propofol.]
[N02AC04, propoxyphene, The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Procaine.]
[C07AA05, propranolol, Procaine may increase the bradycardic activities of Propranolol.]
[N02CC04, rizatriptan, The metabolism of Rizatriptan can be decreased when combined with Procaine.]
[B01AC09, epoprostenol, Procaine may increase the hypotensive activities of Epoprostenol.]
[J04AD01, prothionamide, The risk or severity of methemoglobinemia can be increased when Protionamide is combined with Procaine.]
[N06AA11, protriptyline, Procaine may increase the serotonergic activities of Protriptyline.]
[R01BA02, pseudoephedrine, Procaine may increase the hypertensive activities of Pseudoephedrine.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Procaine.]
[N07XX07, dalfampridine, The risk or severity of seizure can be increased when Procaine is combined with Dalfampridine.]
[A03AB15, diphemanil, Procaine may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Procaine may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, The risk or severity of adverse effects can be increased when Talbutal is combined with Procaine.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Procaine is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Procaine is combined with Captodiame.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Procaine is combined with Styramate.]
[P02CC01, pyrantel, The risk or severity of adverse effects can be increased when Procaine is combined with Pyrantel.]
[J04AK01, pyrazinamide, The risk or severity of methemoglobinemia can be increased when Pyrazinamide is combined with Procaine.]
[N07AA02, pyridostigmine, Pyridostigmine may increase the neuromuscular blocking activities of Procaine.]
[R06AC01, pyrilamine, The risk or severity of adverse effects can be increased when Procaine is combined with Mepyramine.]
[P01BD01, pyrimethamine, The risk or severity of methemoglobinemia can be increased when Pyrimethamine is combined with Procaine.]
[P01AX05, quinacrine, The risk or severity of methemoglobinemia can be increased when Quinacrine is combined with Procaine.]
[C01BA01, quinidine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Procaine.]
[P01BC01, quinine, The risk or severity of methemoglobinemia can be increased when Quinine is combined with Procaine.]
[C02AA01, rescinnamine, Procaine may increase the hypotensive activities of Rescinnamine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Procaine is combined with Reserpine.]
[J04AB02, rifampin, The risk or severity of methemoglobinemia can be increased when Rifampicin is combined with Procaine.]
[G02CA01, ritodrine, The risk or severity of adverse effects can be increased when Procaine is combined with Ritodrine.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Procaine is combined with Oxitriptan.]
[J01AA09, rolitetracycline, The risk or severity of methemoglobinemia can be increased when Rolitetracycline is combined with Procaine.]
[J01FA06, roxithromycin, The risk or severity of methemoglobinemia can be increased when Roxithromycin is combined with Procaine.]
[A07EC01, sulfasalazine, The risk or severity of methemoglobinemia can be increased when Sulfasalazine is combined with Procaine.]
[S01FA02, scopolamine, Procaine may increase the central nervous system depressant (CNS depressant) activities of Scopolamine.]
[N05CA06, secobarbital, The risk or severity of methemoglobinemia can be increased when Secobarbital is combined with Procaine.]
[V04CK01, secretin, The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Procaine.]
[N04BD01, selegiline, The risk or severity of adverse effects can be increased when Procaine is combined with Selegiline.]
[L01FA03, obinutuzumab, The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Procaine.]
[D06BA01, silver sulfadiazine, The risk or severity of methemoglobinemia can be increased when Silver sulfadiazine is combined with Procaine.]
[J01GB08, sisomicin, The risk or severity of methemoglobinemia can be increased when Sisomicin is combined with Procaine.]
[V04CC01, sorbitol, The therapeutic efficacy of Sorbitol can be decreased when used in combination with Procaine.]
[C07AA07, sotalol, Procaine may increase the bradycardic activities of Sotalol.]
[L01CD04, cabazitaxel, The risk or severity of methemoglobinemia can be increased when Cabazitaxel is combined with Procaine.]
[J01FA02, spiramycin, The risk or severity of methemoglobinemia can be increased when Spiramycin is combined with Procaine.]
[C03DA01, spironolactone, Procaine may increase the orthostatic hypotensive activities of Spironolactone.]
